{"gene":"FFAR2","run_date":"2026-04-28T17:46:03","timeline":{"discoveries":[{"year":2002,"finding":"GPR43 (FFAR2) was deorphanized as a G-protein-coupled receptor activated by short-chain fatty acids (SCFAs), with acetate as the primary agonist and propionate, butyrate, formate, and pentanoate also active; receptor activation was confirmed by Ca2+ mobilization, [35S]GTPγS binding assays, and GIRK channel coexpression in Xenopus oocytes; highest expression was found in immune cells.","method":"Ligand bank screening in yeast, transient transfection in mammalian cells (Ca2+ mobilization, [35S]GTPγS binding), Xenopus oocyte GIRK coexpression assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — multiple orthogonal in vitro assays with reconstitution in heterologous systems, foundational deorphanization paper","pmids":["12496283"],"is_preprint":false},{"year":2003,"finding":"FFAR2 (GPR43) was independently confirmed as a SCFA receptor expressed on peripheral blood leukocytes; acetate and propionate were the most potent agonists; receptor activation mobilized intracellular calcium in recombinant systems and in human granulocytes.","method":"Receptor cloning, calcium mobilization assay in recombinant cells and primary human granulocytes, RT-PCR expression analysis","journal":"Biochemical and biophysical research communications","confidence":"High","confidence_rationale":"Tier 1-2 — functional assay in primary human cells, independent replication of deorphanization","pmids":["12684041"],"is_preprint":false},{"year":2009,"finding":"SCFA-GPR43 signaling is necessary for normal resolution of inflammatory responses; GPR43-deficient mice showed exacerbated or unresolved inflammation in colitis, arthritis, and asthma models, with increased inflammatory mediator production by immune cells and increased immune cell recruitment; germ-free mice lacking SCFAs phenocopied GPR43 deficiency.","method":"GPR43 knockout mouse models (colitis, arthritis, asthma), cytokine measurement, immune cell recruitment assays, germ-free mouse experiments","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 — clean KO with multiple disease models and defined cellular phenotypes, highly cited foundational study","pmids":["19865172"],"is_preprint":false},{"year":2011,"finding":"FFAR2 mediates SCFA-triggered GLP-1 secretion from intestinal L cells; SCFAs raised cytosolic Ca2+ in L cells consistent with Gq signaling; mice lacking ffar2 showed reduced SCFA-triggered GLP-1 secretion in vitro and in vivo and impaired glucose tolerance.","method":"Primary colonic culture GLP-1 secretion assay, Ca2+ imaging in primary L cells, Ffar2 knockout mice (in vitro and in vivo GLP-1 measurement, glucose tolerance test), quantitative PCR for receptor expression in FACS-sorted L cells","journal":"Diabetes","confidence":"High","confidence_rationale":"Tier 2 — knockout mice with multiple orthogonal assays (secretion, Ca2+ signaling, glucose tolerance), replicated in vitro and in vivo","pmids":["22190648"],"is_preprint":false},{"year":2011,"finding":"GPR43-mediated SCFA signaling in neutrophils drives chemotaxis; GPR43 acts as a bona fide chemotactic receptor through Gi proteins, activating PKB, p38, and ERK; PI3Kγ, Rac2, p38, and ERK (but not mTOR) are required for GPR43-dependent chemotaxis; chemotaxis was abolished in GPR43-knockout neutrophils.","method":"Bone marrow-derived neutrophil chemotaxis assays (polycarbonate filter, EZ-Taxiscan), GPR43 knockout mice, synthetic agonist phenylacetamide-1, pertussis toxin treatment, pharmacological and genetic inhibition of signaling intermediates, Rac1/2 activation assay","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 — KO neutrophils with multiple pathway inhibitors and orthogonal chemotaxis methods; strong mechanistic dissection","pmids":["21698257"],"is_preprint":false},{"year":2013,"finding":"GPR43 suppresses insulin signaling in adipocytes to inhibit fat accumulation; GPR43-deficient mice are obese on normal diet while adipose-specific GPR43 overexpression keeps mice lean even on high-fat diet; SCFAs activate GPR43 to promote metabolism of lipids and glucose in other tissues; effects were absent under germ-free conditions.","method":"GPR43 knockout mice, adipose-specific GPR43 transgenic mice, germ-free and antibiotic-treated mice, insulin signaling assays in adipocytes, body composition analysis, metabolic phenotyping","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — complementary gain- and loss-of-function mouse models with mechanistic insulin signaling readouts; germ-free controls","pmids":["23652017"],"is_preprint":false},{"year":2013,"finding":"GPR43 on intestinal epithelial cells activates ERK1/2 and p38 MAPK signaling pathways in response to SCFAs, leading to production of chemokines and cytokines that recruit leukocytes and activate effector T cells; GPR43-deficient mice had reduced inflammatory responses and slower pathogen clearance.","method":"GPR43 knockout mice (ethanol, TNBS, C. rodentium models), primary colon epithelial cell isolation, immunohistochemistry, ELISA, flow cytometry, ERK/p38 signaling assays","journal":"Gastroenterology","confidence":"High","confidence_rationale":"Tier 2 — KO mice with multiple inflammation models, defined signaling pathway (ERK/p38 MAPK), multiple orthogonal readouts","pmids":["23665276"],"is_preprint":false},{"year":2015,"finding":"SCFAs binding to GPR43 on colonic epithelial cells stimulates K+ efflux and membrane hyperpolarization, leading to NLRP3 inflammasome activation, which promotes gut epithelial integrity and protects against colitis.","method":"GPR43 knockout mice, dietary fiber/acetate intervention, electrophysiology (K+ efflux, hyperpolarization measurements), NLRP3 inflammasome activation assays, colitis models","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — KO mice plus electrophysiology and inflammasome pathway measurements; novel ionic mechanism identified","pmids":["25828455"],"is_preprint":false},{"year":2015,"finding":"GPR43 in pancreatic β-cells potentiates glucose-stimulated insulin secretion (GSIS) via Gαq- and phospholipase C-dependent increases in IP3 and Ca2+; also promotes β-cell proliferation and differentiation gene expression; HFD-fed GPR43 KO mice develop glucose intolerance due to defective insulin secretion.","method":"GPR43 KO mice (HFD model), isolated murine and human islets ex vivo, Min6 cells, selective GPR43 agonist PA treatment, IP3 and Ca2+ measurements, β-cell mass quantification, gene expression analysis","journal":"Diabetes","confidence":"High","confidence_rationale":"Tier 1-2 — mechanistic signaling (IP3/Ca2+/Gαq/PLC) confirmed in isolated islets and cell line with KO validation in vivo","pmids":["26023106"],"is_preprint":false},{"year":2015,"finding":"FFAR2 signals through divergent G protein pathways: Gαq/11 pathway potentiates GSIS while Gαi/o pathway inhibits GSIS in mouse islets; acetate potentiates GSIS in an FFAR2-dependent manner; mouse and human FFAR2 display different signaling properties in response to selective agonists.","method":"Ffar2 knockout mice, isolated mouse and human islets ex vivo, FFAR2-specific agonists, hyperglycemic clamp studies, Gαq/11 and Gαi/o pathway pharmacology","journal":"Molecular endocrinology (Baltimore, Md.)","confidence":"High","confidence_rationale":"Tier 1-2 — ex vivo islet assays with KO controls and selective pharmacological dissection of G protein pathways","pmids":["26075576"],"is_preprint":false},{"year":2015,"finding":"GPR43 transcription in human monocytes is regulated by XBP1, which binds directly to the GPR43 promoter as a core cis element; TNFα induces GPR43 expression via XBP1 activation.","method":"5'-RACE mapping of TSS, luciferase reporter assays with stepwise deletions, site-directed mutagenesis, ChIP assay confirming XBP1 binding to endogenous GPR43 promoter, siRNA knockdown of XBP1, XBP1 overexpression","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 1-2 — ChIP validation plus multiple mutagenesis/knockdown/overexpression approaches; strong mechanistic characterization of promoter","pmids":["25633224"],"is_preprint":false},{"year":2016,"finding":"FFAR2 (Ffar2) promotes expansion of PYY-producing colonic enteroendocrine cells in response to fermentable carbohydrate (inulin), reducing food intake and preventing diet-induced obesity; this effect requires FFAR2 and involves increased PYY cell density and GLP-1 release.","method":"Ffar2 knockout mice, inulin-supplemented diet, enteroendocrine cell density measurements, intestinal organoids and colonic cultures, gut hormone measurements","journal":"Molecular metabolism","confidence":"High","confidence_rationale":"Tier 2 — KO mouse model with cellular (enteroendocrine cell density) and hormonal readouts, supported by organoid experiments","pmids":["28123937"],"is_preprint":false},{"year":2016,"finding":"GPR43 activation by SCFA acetate promotes intestinal IgA responses; mechanistically, acetate-GPR43 signaling induces dendritic cell expression of Aldh1a2, which converts Vitamin A to retinoic acid (RA), and RA then drives B-cell IgA class switching and IgA production.","method":"GPR43 knockout mice, B cell IgA class switching assays in vitro with WT vs GPR43-/- dendritic cells, Aldh1a2 expression analysis, RA signaling blockade experiments","journal":"Mucosal immunology","confidence":"High","confidence_rationale":"Tier 2 — KO mice plus defined in vitro mechanistic pathway (DC Aldh1a2 → RA → B cell IgA switching)","pmids":["27966553"],"is_preprint":false},{"year":2017,"finding":"FFAR2 and FFAR3 interact to form a receptor heteromer in primary human monocytes and macrophages; the FFAR2-FFAR3 heteromer displays enhanced Ca2+ signaling (~1.5-fold vs homomeric FFAR2) and β-arrestin-2 recruitment (~30-fold vs homomeric FFAR3), lacks cAMP inhibition but gains p38 phosphorylation activity via Gαq and Gαi pathways.","method":"Proximity ligation assay in primary human monocytes/macrophages, bimolecular fluorescence complementation and FRET in HEK293 cells, Ca2+ signaling, β-arrestin-2 recruitment, cAMP, p38 phosphorylation assays, selective antagonists (CATPB, YM254890, pertussis toxin)","journal":"FASEB journal","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods (PLA, BiFC, FRET) in primary and recombinant cells, pharmacological validation with selective inhibitors","pmids":["28883043"],"is_preprint":false},{"year":2018,"finding":"GPR43 mediates SCFA-induced RegIIIγ and β-defensin expression in intestinal epithelial cells via activation of mTOR and STAT3 signaling pathways.","method":"GPR43 knockout mice, intestinal epithelial enteroids from WT and GPR43-/- mice, SCFA treatment, mTOR and STAT3 knockdown, AMP expression quantification","journal":"Mucosal immunology","confidence":"High","confidence_rationale":"Tier 2 — KO organoid model plus siRNA pathway validation; clean mechanistic dissection (SCFA→GPR43→mTOR/STAT3→AMP)","pmids":["29411774"],"is_preprint":false},{"year":2018,"finding":"GPR43 activation results in induction of pro-inflammatory TNF-α in anti-inflammatory M2-type adipose tissue macrophages but not M1-type macrophages, suggesting distinct macrophage-type-dependent GPR43 functions in adipose tissue homeostasis.","method":"Gpr43-deficient mice, adipose-specific GPR43 transgenic mice, adipose tissue macrophage isolation, cytokine expression assays, M1/M2 macrophage differentiation","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 — KO and transgenic mice with defined cellular readouts, but single lab study","pmids":["28692672"],"is_preprint":false},{"year":2018,"finding":"GPR43-dependent ERK phosphorylation and NLRP3 inflammasome activation in non-hematopoietic host tissues mediates SCFA protection against GVHD; specifically propionate and butyrate signal through GPR43 for these protective effects.","method":"Multiple murine GVHD models, GPR43 knockout mice, co-housing/antibiotic treatment/exogenous SCFA administration, ERK phosphorylation assays, NLRP3 inflammasome assays","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — multiple GVHD models with KO validation plus defined signaling (ERK/NLRP3); multiple mechanistic controls","pmids":["30201970"],"is_preprint":false},{"year":2019,"finding":"FFAR2 promotes IAV internalization into host cells via a signaling cascade involving β-arrestin1 interaction with the β2-subunit of the AP-2 adaptor complex (AP2B1), facilitating clathrin-mediated endocytosis; FFAR2 also interacts with GRK2, GRK5, and GRK6 which are required for efficient IAV replication.","method":"siRNA knockdown of FFAR2 in A549 and RAW264.7 cells, co-immunoprecipitation (FFAR2–β-arrestin1, β-arrestin1–AP2B1), nuclear NP accumulation assay, virus internalization quantification, Barbadin inhibitor treatment, siRNA knockdown of AP2B1 and GRKs","journal":"Journal of virology","confidence":"High","confidence_rationale":"Tier 1-2 — Co-IP demonstrating protein interactions, KD phenotype with mechanistic pathway (FFAR2→β-arrestin1→AP2B1→clathrin endocytosis), multiple orthogonal controls","pmids":["31694949"],"is_preprint":false},{"year":2019,"finding":"Ffar2 on colonic ILC3s promotes their in situ proliferation and IL-22 production via AKT and STAT3 signaling; Ffar2 agonism differentially activates AKT or ERK; Ffar2 deficiency in ILC3s decreases IL-22+ CCR6+ ILC3s and impairs gut barrier function.","method":"ILC3-specific Ffar2 conditional analysis, Ffar2 agonism in colonic cultures, AKT/ERK/STAT3 pathway analysis, ILC3 proliferation measurement, IL-22 production assays, colonic injury and bacterial infection models","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 2 — defined receptor-to-signaling pathway (Ffar2→AKT→STAT3→IL-22) with ILC3-specific functional readouts and infection phenotype","pmids":["31628054"],"is_preprint":false},{"year":2019,"finding":"Acetoacetate is identified as an endogenous agonist for GPR43 under ketogenic conditions; under fasting or ketogenic diet, plasma acetoacetate increases while SCFAs decrease; Gpr43-deficient mice show reduced weight loss and suppressed lipoprotein lipase activity during fasting.","method":"Ligand screening in heterologous expression system, Gpr43-deficient mice under fasting/ketogenic diet, plasma acetoacetate and SCFA measurement, lipoprotein lipase activity assay, gut microbiota composition analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1-2 — ligand identification in heterologous system plus KO mouse with defined metabolic phenotype under controlled nutritional conditions","pmids":["31685604"],"is_preprint":false},{"year":2019,"finding":"Propionate suppresses hepatic gluconeogenesis via GPR43 activation: GPR43 binding triggers intracellular Ca2+ increase → CaMKKβ activation → AMPK phosphorylation → downregulation of G6Pase and PEPCK; siRNA knockdown of GPR43 abolishes propionate-induced AMPK activation and anti-gluconeogenic effects.","method":"HepG2 hepatocytes, siRNA knockdown of GPR43, intracellular Ca2+ measurement, CaMKKβ inhibitor, AMPK phosphorylation assay, G6Pase/PEPCK expression analysis, glucose production assay","journal":"Archives of biochemistry and biophysics","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro mechanistic dissection with siRNA KD, Ca2+ measurements, and kinase cascade delineation in human hepatocytes","pmids":["31356781"],"is_preprint":false},{"year":2019,"finding":"GPR43 activation by acetate in pulmonary epithelial cells mediates antiviral interferon-β (IFN-β) response against RSV; IFNAR signaling is essential for acetate antiviral activity; effects were abolished in Gpr43-/- mice.","method":"Gpr43 knockout mice (RSV infection model), pulmonary epithelial cell lines with GPR43 activation/knockdown, IFN-β measurement, IFNAR blocking, viral load quantification, ISG expression analysis","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — KO mice plus cell line mechanistic studies linking GPR43 to IFN-β pathway, epistatic validation with IFNAR knockout","pmids":["31332169"],"is_preprint":false},{"year":2020,"finding":"Acetate-FFAR2 signaling coordinates neutrophil and ILC3 responses against C. difficile: in neutrophils, acetate-FFAR2 accelerates recruitment, facilitates inflammasome activation, and promotes IL-1β release; in ILC3s, acetate-FFAR2 augments IL-1R expression, boosting IL-22 secretion in response to IL-1β.","method":"FFAR2 knockout mice (acute CDI model), acetate administration, neutrophil recruitment/inflammasome/IL-1β assays, ILC3 IL-1R expression and IL-22 secretion measurement","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 — KO mice with mechanistic dissection of two distinct cell type pathways (neutrophil inflammasome vs ILC3 IL-1R/IL-22)","pmids":["31876919"],"is_preprint":false},{"year":2020,"finding":"Acetic acid activates GPR43 in L6 skeletal muscle myotubes, inducing intracellular Ca2+ influx that activates calcineurin, leading to nuclear localization of MEF2A, PGC-1α, and NFATc1, thereby promoting slow-twitch fiber proliferation-related gene expression; GPR43 siRNA abolishes these effects.","method":"L6 myotube cells, GPR43 siRNA knockdown, Ca2+ imaging, calcineurin activity assay, nuclear localization assays for MEF2A/PGC-1α/NFATc1, RT-PCR","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 — siRNA KD with Ca2+ and nuclear translocation measurements in cell line, but single lab study","pmids":["32997697"],"is_preprint":false},{"year":2006,"finding":"GPR43 is expressed in enteroendocrine cells (PYY-positive, not 5-HT-positive) and mucosal mast cells in rat intestine, with protein localized to these specific cell types; no GPR43 was detected in smooth muscle or submucosa.","method":"RT-PCR, Western blotting, immunohistochemistry with antibody raised against rat GPR43 peptide fragment, co-localization with PYY and 5-HT markers","journal":"Cell and tissue research","confidence":"Medium","confidence_rationale":"Tier 2 — direct protein localization with specific antibody and co-localization markers, but no functional consequence directly tested","pmids":["16453106"],"is_preprint":false},{"year":2006,"finding":"SCFAs activate GPR43 in MCF-7 breast cancer cells to selectively phosphorylate p38 MAPK and its downstream substrate HSP27 (at Ser-78 and Ser-82 but not Ser-15); propionate-induced Ca2+ elevation and p38 phosphorylation were inhibited by GPR43-specific siRNA.","method":"RT-PCR expression, intracellular Ca2+ measurement, cAMP assay, phospho-p38 and phospho-HSP27 Western blot, GPR43-specific siRNA knockdown","journal":"Cellular signalling","confidence":"Medium","confidence_rationale":"Tier 2 — siRNA KD with Ca2+ and kinase substrate measurements in cell line; moderate evidence from single lab","pmids":["16887331"],"is_preprint":false},{"year":2016,"finding":"FFAR2 in adipocytes signals via the Gi/o–Gβγ–phospholipase C–PKC–MAPK kinase pathway to stimulate adipogenesis and mitochondrial biogenesis in brown adipocytes; acetate activates ERK and CREB via this pathway, with effects mimicked by a synthetic GPR43 agonist and impaired by GPR43 knockdown.","method":"Brown adipocyte cell culture, Gi/o inhibitor (PTX), Gβγ inhibitor, PLC inhibitor, MEK inhibitor, GPR43 knockdown, ERK/CREB phosphorylation assays, mitochondrial biogenesis markers, adipogenic gene expression","journal":"Endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 — pharmacological pathway dissection with KD validation in cell line, single lab","pmids":["26990063"],"is_preprint":false},{"year":2017,"finding":"Sodium butyrate protects against LPS-induced liver injury via a GPR43/β-arrestin-2/NF-κB pathway; butyrate treatment increases interaction between GPR43 and β-arrestin-2, and between β-arrestin-2 and IκBα, thereby suppressing NF-κB activation; protective effects were weakened in GPR43-KO mice and GPR43 siRNA-treated cells.","method":"GPR43 KO mice (LPS model), GPR43 siRNA in RAW264.7 cells, co-immunoprecipitation (GPR43–β-arrestin-2, β-arrestin-2–IκBα), NF-κB/TLR4 pathway Western blot, cytokine measurement","journal":"Gastroenterology report","confidence":"Medium","confidence_rationale":"Tier 2 — Co-IP demonstrating protein interactions with KO validation, but single lab study","pmids":["34026223"],"is_preprint":false},{"year":2021,"finding":"FFAR2 signaling in MDSC suppresses T cell function through Gαq/calcium/PPAR-γ/Arg1 axis; FFAR2 deficiency in MDSCs reduces Arg1 expression, relieving L-Arginine consumption and restoring T cell activity in the tumor microenvironment; FFAR2 inhibition enhances response to immune checkpoint blockade.","method":"Whole/myeloid Ffar2 knockout mice (lung carcinogenesis models), flow cytometry, RNA sequencing, Western blotting, L-Arginine replenishment, PPAR-γ inhibition, Gαq/calcium pathway analysis","journal":"Journal of hematology & oncology","confidence":"Medium","confidence_rationale":"Tier 2 — KO models with defined signaling pathway and functional T cell readouts; single lab but multiple orthogonal approaches","pmids":["38402237"],"is_preprint":false},{"year":2023,"finding":"Butyrate promotes ferroptosis via FFAR2: FFAR2 activation by butyrate suppresses SLC7A11 via the FFAR2-AKT-NRF2 axis and suppresses GPX4 via the FFAR2-mTORC1 axis, both in a cAMP-PKA-dependent manner, leading to lipid ROS accumulation.","method":"Ferroptosis assays (RSL3/erastin), FFAR2 knockdown/overexpression, AKT/NRF2 pathway analysis, mTORC1 inhibition, SLC7A11 and GPX4 expression, cAMP-PKA pathway analysis, xenograft and colorectal carcinogenesis models","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 — mechanistic pathway dissection with KD and pharmacological tools in cell lines plus in vivo validation; single lab","pmids":["37185889"],"is_preprint":false},{"year":2022,"finding":"GPR43 activation by SCFAs inhibits NLRP3 inflammasome-mediated atrial remodeling to protect against atrial fibrillation; GPR43 knockdown in HL-1 atrial cells abolished the protective effects of SCFAs on NLRP3 deactivation.","method":"Low/high fiber diet mouse model, burst pacing AF model, HL-1 cells with GPR43 knockdown, NLRP3 inflammasome activity assay, CaMKII phosphorylation and RyR2 phosphorylation measurement, collagen/fibrosis analysis","journal":"International journal of biological sciences","confidence":"Medium","confidence_rationale":"Tier 2 — in vitro KD mechanistic validation with in vivo diet model; single lab but defined signaling pathway","pmids":["35844801"],"is_preprint":false},{"year":2022,"finding":"GPR43 activation by SCFA acetate in podocytes activates the ERK/EGR1 pathway, increasing LDLR expression and inhibiting cholesterol autophagy, leading to cholesterol accumulation and lipotoxic podocyte injury in diabetic nephropathy; GPR43 gene deletion or pharmacological inhibition prevents these effects.","method":"Diabetic GPR43-knockout mice, podocyte cell culture, BODIPY staining, cholesterol assays, ERK1/2 and EGR1 expression, LC3/p62/beclin1 autophagy markers, LDLR expression, GPR43 siRNA and pharmacological inhibition","journal":"International journal of biological sciences","confidence":"Medium","confidence_rationale":"Tier 2 — KO mice plus in vitro mechanistic pathway (GPR43→ERK→EGR1→LDLR/autophagy), single lab","pmids":["34975320"],"is_preprint":false},{"year":2020,"finding":"FFAR2 mediates SCFA-induced SCFA-dependent innate defense against IAV through type 1 interferon (IFN-β) response in pulmonary epithelial cells; Gpr43-knockout mice lose the protective antiviral effects of dietary fiber/acetate.","method":"Gpr43 knockout mice (RSV model also covers IAV in context of antiviral signaling), pulmonary epithelial cell line FFAR2 activation, IFN-β measurement, IFNAR pathway analysis","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — already captured in RSV paper (PMID 31332169); same mechanistic pathway","pmids":["31332169"],"is_preprint":false},{"year":2021,"finding":"GPR43 activation by acetate primes neutrophils for enhanced chemotaxis, oxidative burst, cytokine release, and upregulation of phagocytic receptors; acetate administration rescues wild-type but not GPR43-deficient mice from severe S. aureus sepsis.","method":"Human neutrophil priming assays, GPR43-deficient mice (S. aureus sepsis model), acetate administration, ROS/oxidative burst assay, cytokine measurement, phagocytic receptor expression, bacterial load quantification","journal":"Communications biology","confidence":"Medium","confidence_rationale":"Tier 2 — human neutrophil functional assays plus KO mouse sepsis model; single lab","pmids":["34330996"],"is_preprint":false},{"year":2025,"finding":"Propionic acid activates GPR43 to enhance PINK1/PARKIN-mediated mitophagy in neuronal cells, while activating GPR41 to downregulate DRP1-mediated mitochondrial fission, thereby maintaining mitochondrial homeostasis in an Alzheimer's disease model.","method":"AD mouse model with oral propionate supplementation, cultured hippocampal neurons, GPR43 and GPR41 pathway analysis, DRP1/mitochondrial fission protein expression, PINK1/PARKIN mitophagy markers, cognitive behavioral tests","journal":"Microbiome","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo and in vitro with defined pathway (GPR43→PINK1/PARKIN mitophagy), but distinguishing GPR41 vs GPR43 roles requires care; single lab","pmids":["39833898"],"is_preprint":false}],"current_model":"FFAR2 (GPR43) is a seven-transmembrane G-protein-coupled receptor activated by short-chain fatty acids (primarily acetate, propionate, and butyrate) and ketone body acetoacetate, which couples to both Gαi/o (inhibiting cAMP, mediating chemotaxis) and Gαq/11 (mobilizing Ca2+, activating PLC/IP3, stimulating NLRP3 inflammasome and K+ efflux) pathways depending on cell type and ligand, and can also signal through β-arrestin-2 to suppress NF-κB; it drives diverse downstream effects including ERK/p38 MAPK activation, mTOR/STAT3 signaling, AMPK activation via CaMKKβ, and AKT/NRF2 modulation, with defined roles in neutrophil chemotaxis and priming, intestinal ILC3 proliferation and IL-22 production, GLP-1 and PYY secretion from enteroendocrine cells, insulin secretion potentiation in β-cells, suppression of adipocyte insulin signaling to regulate fat accumulation, antimicrobial peptide induction in intestinal epithelium, intestinal IgA responses via dendritic cell retinoic acid production, and antiviral IFN-β signaling in lung epithelial cells."},"narrative":{"teleology":[{"year":2002,"claim":"Resolving the orphan status of GPR43, SCFA ligand screening established that acetate, propionate, and butyrate activate this GPCR, with Ca²⁺ mobilization and GTPγS binding confirming functional coupling — founding the field of SCFA receptor biology.","evidence":"Ligand bank screening in yeast, Ca²⁺ mobilization and [³⁵S]GTPγS binding in mammalian cells, GIRK channel coexpression in Xenopus oocytes","pmids":["12496283"],"confidence":"High","gaps":["Downstream G-protein identity not resolved","No in vivo functional data","Endogenous cellular context unknown"]},{"year":2003,"claim":"Independent replication in primary human granulocytes confirmed FFAR2 as a functional SCFA receptor on immune cells, establishing that leukocytes are a primary site of FFAR2 action.","evidence":"Ca²⁺ mobilization in recombinant cells and primary human granulocytes, RT-PCR expression profiling","pmids":["12684041"],"confidence":"High","gaps":["Specific immune cell functions mediated by FFAR2 not yet defined","G-protein coupling pathway not delineated"]},{"year":2006,"claim":"Cellular localization studies placed FFAR2 protein in intestinal PYY-positive enteroendocrine cells and mucosal mast cells, while signaling studies in MCF-7 cells identified selective p38 MAPK and HSP27 phosphorylation downstream of FFAR2, beginning to define tissue-specific signaling.","evidence":"Immunohistochemistry with co-localization markers in rat intestine; siRNA knockdown with p38/HSP27 phosphorylation in MCF-7 cells","pmids":["16453106","16887331"],"confidence":"Medium","gaps":["Functional consequence of enteroendocrine localization not tested","p38 pathway relevance in immune cells not established"]},{"year":2009,"claim":"The first loss-of-function in vivo study demonstrated that FFAR2 is required for resolution of inflammatory responses, as KO mice showed exacerbated colitis, arthritis, and asthma — establishing FFAR2 as a bona fide mediator of microbiota-immune communication.","evidence":"GPR43 knockout mice in colitis, arthritis, and asthma models; germ-free mice phenocopying KO","pmids":["19865172"],"confidence":"High","gaps":["Cell-type-specific contributions not dissected","Downstream signaling pathways in vivo not identified"]},{"year":2011,"claim":"Mechanistic dissection resolved that FFAR2 functions as a Gi-coupled chemotactic receptor in neutrophils through PI3Kγ/Rac2/p38/ERK, while simultaneously showing that it drives GLP-1 secretion from L cells via Gq/Ca²⁺ — demonstrating cell-type-dependent G-protein coupling.","evidence":"KO neutrophil chemotaxis with pathway inhibitors; KO mouse GLP-1 secretion with Ca²⁺ imaging in primary L cells","pmids":["21698257","22190648"],"confidence":"High","gaps":["How cell-type context determines Gi vs Gq preference unknown","β-arrestin signaling arm not yet explored"]},{"year":2013,"claim":"Complementary gain- and loss-of-function mouse models established that FFAR2 suppresses adipocyte insulin signaling to regulate fat accumulation and promotes intestinal epithelial ERK/p38 cytokine responses for pathogen clearance, extending FFAR2's role beyond immune cells to metabolic and barrier tissues.","evidence":"Adipose-specific transgenic and global KO mice with metabolic phenotyping; KO mice in colitis/infection models with ERK/p38 signaling assays","pmids":["23652017","23665276"],"confidence":"High","gaps":["Direct adipocyte signaling intermediates downstream of insulin inhibition not fully mapped","Whether epithelial and immune FFAR2 functions are synergistic or independent unclear"]},{"year":2015,"claim":"Three studies resolved key signaling branches: FFAR2 activates NLRP3 inflammasome via K⁺ efflux in colonic epithelium for barrier protection, potentiates GSIS through Gαq/PLC/IP3/Ca²⁺ in β-cells, and displays species-specific divergent Gαq vs Gαi/o coupling — revealing that the same receptor can drive opposing metabolic outputs depending on G-protein engagement.","evidence":"KO mice with electrophysiology for K⁺ efflux/NLRP3; isolated islets with IP3/Ca²⁺ measurements and hyperglycemic clamps; selective agonist pharmacology on mouse vs human islets","pmids":["25828455","26023106","26075576"],"confidence":"High","gaps":["Structural basis for differential G-protein coupling not known","Species differences between mouse and human FFAR2 complicate translation"]},{"year":2015,"claim":"Identification of XBP1 as a transcriptional regulator binding the FFAR2 promoter in monocytes, induced by TNFα, established how FFAR2 expression is upregulated during inflammation.","evidence":"ChIP, luciferase reporters with mutagenesis, siRNA knockdown and overexpression of XBP1 in human monocytes","pmids":["25633224"],"confidence":"High","gaps":["Other transcription factors regulating FFAR2 not identified","Whether XBP1 regulation applies in non-monocyte cell types unknown"]},{"year":2016,"claim":"FFAR2 was shown to promote enteroendocrine cell expansion for PYY production and to induce dendritic cell Aldh1a2 expression for retinoic acid–driven IgA class switching, revealing receptor functions in gut hormone homeostasis and adaptive mucosal immunity.","evidence":"KO mice with inulin diet and enteroendocrine cell quantification; KO mice with DC co-culture IgA switching assays and Aldh1a2 expression","pmids":["28123937","27966553"],"confidence":"High","gaps":["Signaling pathway linking FFAR2 to Aldh1a2 induction not defined","Whether FFAR2 directly drives enteroendocrine progenitor differentiation or only proliferation unclear"]},{"year":2017,"claim":"Discovery that FFAR2 and FFAR3 form functional heteromers with altered signaling properties (enhanced Ca²⁺, gain of β-arrestin-2 recruitment, loss of cAMP inhibition) introduced receptor heteromerization as a mechanism for SCFA signaling diversification in monocytes/macrophages; simultaneously, a β-arrestin-2–mediated anti-inflammatory pathway (suppressing NF-κB via IκBα stabilization) was delineated.","evidence":"PLA in primary monocytes, BiFC/FRET in HEK293, Ca²⁺/cAMP/p38 assays for heteromer; Co-IP of GPR43–β-arrestin-2 and β-arrestin-2–IκBα with KO validation for NF-κB suppression","pmids":["28883043","34026223"],"confidence":"High","gaps":["Physiological relevance of heteromer vs homomer ratio in vivo not determined","β-arrestin-2/NF-κB finding from single lab awaits independent replication"]},{"year":2018,"claim":"FFAR2 was linked to antimicrobial peptide (RegIIIγ, β-defensin) induction in intestinal epithelium through mTOR/STAT3, and to GVHD protection through ERK/NLRP3 in non-hematopoietic tissues, broadening the receptor's epithelial defense repertoire.","evidence":"KO enteroids with mTOR/STAT3 knockdown for AMP expression; KO mice in multiple GVHD models with ERK/NLRP3 assays","pmids":["29411774","30201970"],"confidence":"High","gaps":["How mTOR/STAT3 and NLRP3 pathways are differentially engaged in different epithelial contexts not resolved"]},{"year":2019,"claim":"A burst of discoveries expanded FFAR2 biology in four directions: identification of acetoacetate as an endogenous ketogenic agonist; definition of the Ca²⁺/CaMKKβ/AMPK pathway suppressing hepatic gluconeogenesis; demonstration that FFAR2 on ILC3s drives IL-22 via AKT/STAT3 for gut barrier defense; and the antiviral IFN-β response in lung epithelium against RSV.","evidence":"Heterologous ligand screening plus KO mice under ketogenic conditions; HepG2 siRNA with Ca²⁺/AMPK cascade; ILC3 conditional analysis with AKT/STAT3/IL-22; KO mice in RSV model with IFN-β measurement","pmids":["31685604","31356781","31628054","31332169"],"confidence":"High","gaps":["Relative contribution of acetoacetate vs SCFAs under mixed metabolic states unknown","Whether ILC3 and neutrophil FFAR2 pathways are coordinated in vivo not fully resolved"]},{"year":2019,"claim":"FFAR2 was found to facilitate influenza virus internalization via β-arrestin-1/AP2B1/clathrin-mediated endocytosis, with GRK2/5/6 involvement — an unexpected pro-viral function distinct from its antiviral IFN-β activity in epithelial cells.","evidence":"siRNA knockdown of FFAR2 in A549/RAW264.7 cells, Co-IP of FFAR2–β-arrestin-1 and β-arrestin-1–AP2B1, virus internalization quantification","pmids":["31694949"],"confidence":"High","gaps":["How pro-viral endocytosis and antiviral IFN-β functions coexist in the same cell type not reconciled","In vivo relevance of FFAR2 in IAV pathogenesis not tested with KO mice"]},{"year":2020,"claim":"FFAR2 was shown to coordinate innate immunity against C. difficile by accelerating neutrophil inflammasome/IL-1β release and upregulating ILC3 IL-1R/IL-22 — establishing a two-cell-type cooperative circuit mediated by a single receptor.","evidence":"FFAR2 KO mice in acute CDI model with neutrophil and ILC3 functional assays","pmids":["31876919"],"confidence":"High","gaps":["Whether this cooperative circuit operates in other enteric infections not tested"]},{"year":2021,"claim":"FFAR2 on MDSCs was shown to suppress anti-tumor T cell responses through Gαq/Ca²⁺/PPARγ/Arg1 axis, and FFAR2 inhibition enhanced checkpoint blockade — defining a tumor-promoting immunosuppressive function of FFAR2 distinct from its anti-inflammatory roles.","evidence":"Myeloid-specific Ffar2 KO mice in lung carcinogenesis, RNA-seq, L-Arg replenishment, PPARγ inhibition","pmids":["38402237"],"confidence":"Medium","gaps":["Generalizability across tumor types not established","Whether FFAR2 MDSC function is ligand-specific not resolved","Single lab study"]},{"year":2023,"claim":"FFAR2 was linked to ferroptosis induction via dual suppression of SLC7A11 (through AKT/NRF2) and GPX4 (through mTORC1) in a cAMP-PKA-dependent manner, expanding the receptor's role to regulated cell death.","evidence":"FFAR2 knockdown/overexpression with ferroptosis assays, AKT/NRF2 and mTORC1 pathway analysis, xenograft models","pmids":["37185889"],"confidence":"Medium","gaps":["Physiological relevance of FFAR2-driven ferroptosis in normal tissue not established","cAMP-PKA dependence seems at odds with Gi-mediated cAMP inhibition — reconciliation needed","Single lab study"]},{"year":null,"claim":"Major unresolved questions include the structural basis for FFAR2's differential G-protein coupling across cell types, the physiological balance between pro-viral and antiviral FFAR2 functions, the in vivo stoichiometry and significance of FFAR2-FFAR3 heteromers, and whether FFAR2's tumor-promoting immunosuppressive activity can be therapeutically targeted without compromising its protective immune and metabolic roles.","evidence":"","pmids":[],"confidence":"High","gaps":["No cryo-EM or crystal structure of FFAR2 in active state with different G proteins","Lack of conditional tissue-specific KO studies distinguishing cell-autonomous vs non-cell-autonomous effects in most contexts","Species differences between mouse and human FFAR2 pharmacology limit translational confidence"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[0,1,19]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[5,8,28]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,1,13,24]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[17]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,1,4,8,9,13,25,26]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[2,4,12,18,22,33]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[5,19,20]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[29]}],"complexes":["FFAR2-FFAR3 heteromer"],"partners":["FFAR3","ARRB2","ARRB1","AP2B1","GRK2","XBP1"],"other_free_text":[]},"mechanistic_narrative":"FFAR2 (GPR43) is a G-protein-coupled receptor for short-chain fatty acids and the ketone body acetoacetate that transduces microbiota-derived metabolic signals into immune, metabolic, and epithelial barrier responses across diverse tissues [PMID:12496283, PMID:31685604]. It couples to Gαq/11 to mobilize intracellular Ca²⁺ and activate PLC/IP3, ERK/p38 MAPK, mTOR/STAT3, and NLRP3 inflammasome pathways, and to Gαi/o to inhibit cAMP and drive chemotaxis through PI3Kγ/Rac2, while also engaging β-arrestin-2 to suppress NF-κB signaling [PMID:26075576, PMID:21698257, PMID:25828455, PMID:34026223]. These divergent signaling cascades underpin FFAR2's roles in neutrophil chemotaxis and priming, ILC3 proliferation and IL-22 production, GLP-1 and PYY secretion from enteroendocrine cells, glucose-stimulated insulin secretion in β-cells, suppression of adipocyte insulin signaling, antimicrobial peptide induction via mTOR/STAT3, dendritic cell–driven IgA responses, and antiviral IFN-β production in pulmonary epithelium [PMID:31628054, PMID:22190648, PMID:26023106, PMID:23652017, PMID:29411774, PMID:27966553, PMID:31332169]. FFAR2 also forms functional heteromers with FFAR3 that alter signaling output in monocytes and macrophages [PMID:28883043]."},"prefetch_data":{"uniprot":{"accession":"O15552","full_name":"Free fatty acid receptor 2","aliases":["G-protein coupled receptor 43"],"length_aa":330,"mass_kda":37.1,"function":"G protein-coupled receptor that is activated by a major product of dietary fiber digestion, the short chain fatty acids (SCFAs), and that plays a role in the regulation of whole-body energy homeostasis and in intestinal immunity. In omnivorous mammals, the short chain fatty acids acetate, propionate and butyrate are produced primarily by the gut microbiome that metabolizes dietary fibers. SCFAs serve as a source of energy but also act as signaling molecules. That G protein-coupled receptor is probably coupled to the pertussis toxin-sensitive, G(i/o)-alpha family of G proteins but also to the Gq family (PubMed:12496283, PubMed:12711604, PubMed:23589301). Its activation results in the formation of inositol 1,4,5-trisphosphate, the mobilization of intracellular calcium, the phosphorylation of the MAPK3/ERK1 and MAPK1/ERK2 kinases and the inhibition of intracellular cAMP accumulation. May play a role in glucose homeostasis by regulating the secretion of GLP-1, in response to short-chain fatty acids accumulating in the intestine. May also regulate the production of LEP/Leptin, a hormone acting on the central nervous system to inhibit food intake. Finally, may also regulate whole-body energy homeostasis through adipogenesis regulating both differentiation and lipid storage of adipocytes. In parallel to its role in energy homeostasis, may also mediate the activation of the inflammatory and immune responses by SCFA in the intestine, regulating the rapid production of chemokines and cytokines. May also play a role in the resolution of the inflammatory response and control chemotaxis in neutrophils. In addition to SCFAs, may also be activated by the extracellular lectin FCN1 in a process leading to activation of monocytes and inducing the secretion of interleukin-8/IL-8 in response to the presence of microbes (PubMed:21037097). Among SCFAs, the fatty acids containing less than 6 carbons, the most potent activators are probably acetate, propionate and butyrate (PubMed:12496283, PubMed:12711604). Exhibits a SCFA-independent constitutive G protein-coupled receptor activity (PubMed:23066016)","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/O15552/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/FFAR2","classification":"Not Classified","n_dependent_lines":49,"n_total_lines":1208,"dependency_fraction":0.04056291390728477},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/FFAR2","total_profiled":1310},"omim":[{"mim_id":"603823","title":"FREE FATTY ACID RECEPTOR 2; FFAR2","url":"https://www.omim.org/entry/603823"},{"mim_id":"603821","title":"FREE FATTY ACID RECEPTOR 3; FFAR3","url":"https://www.omim.org/entry/603821"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"bone marrow","ntpm":19.1},{"tissue":"lymphoid tissue","ntpm":21.0}],"url":"https://www.proteinatlas.org/search/FFAR2"},"hgnc":{"alias_symbol":["FFA2R"],"prev_symbol":["GPR43"]},"alphafold":{"accession":"O15552","domains":[{"cath_id":"1.20.1070.10","chopping":"6-152_160-290","consensus_level":"high","plddt":93.7319,"start":6,"end":290}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O15552","model_url":"https://alphafold.ebi.ac.uk/files/AF-O15552-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O15552-F1-predicted_aligned_error_v6.png","plddt_mean":88.06},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=FFAR2","jax_strain_url":"https://www.jax.org/strain/search?query=FFAR2"},"sequence":{"accession":"O15552","fasta_url":"https://rest.uniprot.org/uniprotkb/O15552.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O15552/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O15552"}},"corpus_meta":[{"pmid":"19865172","id":"PMC_19865172","title":"Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43.","date":"2009","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/19865172","citation_count":2439,"is_preprint":false},{"pmid":"12496283","id":"PMC_12496283","title":"The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12496283","citation_count":1835,"is_preprint":false},{"pmid":"22190648","id":"PMC_22190648","title":"Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2.","date":"2011","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/22190648","citation_count":1734,"is_preprint":false},{"pmid":"23652017","id":"PMC_23652017","title":"The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43.","date":"2013","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/23652017","citation_count":1116,"is_preprint":false},{"pmid":"25828455","id":"PMC_25828455","title":"Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome.","date":"2015","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/25828455","citation_count":1053,"is_preprint":false},{"pmid":"23665276","id":"PMC_23665276","title":"Short-chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice.","date":"2013","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/23665276","citation_count":853,"is_preprint":false},{"pmid":"12684041","id":"PMC_12684041","title":"Identification of a free fatty acid receptor, FFA2R, expressed on leukocytes and activated by short-chain fatty acids.","date":"2003","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/12684041","citation_count":442,"is_preprint":false},{"pmid":"23885020","id":"PMC_23885020","title":"GPR41/FFAR3 and GPR43/FFAR2 as cosensors for short-chain fatty acids in enteroendocrine cells vs FFAR3 in enteric neurons and FFAR2 in enteric leukocytes.","date":"2013","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/23885020","citation_count":438,"is_preprint":false},{"pmid":"27966553","id":"PMC_27966553","title":"Microbiota metabolite short-chain fatty acid acetate promotes intestinal IgA response to microbiota which is mediated by GPR43.","date":"2016","source":"Mucosal immunology","url":"https://pubmed.ncbi.nlm.nih.gov/27966553","citation_count":390,"is_preprint":false},{"pmid":"29411774","id":"PMC_29411774","title":"GPR43 mediates microbiota metabolite SCFA regulation of antimicrobial peptide expression in intestinal epithelial cells via activation of mTOR and STAT3.","date":"2018","source":"Mucosal immunology","url":"https://pubmed.ncbi.nlm.nih.gov/29411774","citation_count":383,"is_preprint":false},{"pmid":"16453106","id":"PMC_16453106","title":"Short-chain fatty acid receptor, GPR43, is expressed by enteroendocrine cells and mucosal mast cells in rat intestine.","date":"2006","source":"Cell and tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/16453106","citation_count":359,"is_preprint":false},{"pmid":"31332169","id":"PMC_31332169","title":"Microbiota-derived acetate protects against respiratory syncytial virus infection through a GPR43-type 1 interferon response.","date":"2019","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/31332169","citation_count":307,"is_preprint":false},{"pmid":"18812643","id":"PMC_18812643","title":"Roles of short-chain fatty acids receptors, GPR41 and GPR43 on colonic functions.","date":"2008","source":"Journal of physiology and pharmacology : an official journal of the Polish Physiological Society","url":"https://pubmed.ncbi.nlm.nih.gov/18812643","citation_count":302,"is_preprint":false},{"pmid":"32358041","id":"PMC_32358041","title":"Dietary Fiber Protects against Diabetic Nephropathy through Short-Chain Fatty Acid-Mediated Activation of G Protein-Coupled Receptors GPR43 and GPR109A.","date":"2020","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/32358041","citation_count":285,"is_preprint":false},{"pmid":"31628054","id":"PMC_31628054","title":"Metabolite-Sensing Receptor Ffar2 Regulates Colonic Group 3 Innate Lymphoid Cells and Gut Immunity.","date":"2019","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/31628054","citation_count":268,"is_preprint":false},{"pmid":"20399779","id":"PMC_20399779","title":"Roles of GPR41 and GPR43 in leptin secretory responses of murine adipocytes to short chain fatty acids.","date":"2010","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/20399779","citation_count":259,"is_preprint":false},{"pmid":"17899402","id":"PMC_17899402","title":"Expression of the short-chain fatty acid receptor, GPR43, in the human colon.","date":"2007","source":"Journal of molecular histology","url":"https://pubmed.ncbi.nlm.nih.gov/17899402","citation_count":244,"is_preprint":false},{"pmid":"26870043","id":"PMC_26870043","title":"GPR41 and GPR43 in Obesity and Inflammation - Protective or Causative?","date":"2016","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/26870043","citation_count":241,"is_preprint":false},{"pmid":"21698257","id":"PMC_21698257","title":"SCFAs induce mouse neutrophil chemotaxis through the GPR43 receptor.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21698257","citation_count":215,"is_preprint":false},{"pmid":"24926285","id":"PMC_24926285","title":"The SCFA Receptor GPR43 and Energy Metabolism.","date":"2014","source":"Frontiers in endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/24926285","citation_count":205,"is_preprint":false},{"pmid":"23060857","id":"PMC_23060857","title":"Short-chain free fatty acid receptors FFA2/GPR43 and FFA3/GPR41 as new potential therapeutic targets.","date":"2012","source":"Frontiers in endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/23060857","citation_count":204,"is_preprint":false},{"pmid":"25914377","id":"PMC_25914377","title":"A Role for Gut Microbiota and the Metabolite-Sensing Receptor GPR43 in a Murine Model of Gout.","date":"2015","source":"Arthritis & rheumatology (Hoboken, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/25914377","citation_count":197,"is_preprint":false},{"pmid":"21115338","id":"PMC_21115338","title":"Inulin-type fructans with prebiotic properties counteract GPR43 overexpression and PPARγ-related adipogenesis in the white adipose tissue of high-fat diet-fed mice.","date":"2010","source":"The Journal of nutritional biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21115338","citation_count":189,"is_preprint":false},{"pmid":"28123937","id":"PMC_28123937","title":"Fermentable carbohydrate stimulates FFAR2-dependent colonic PYY cell expansion to increase satiety.","date":"2016","source":"Molecular metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/28123937","citation_count":188,"is_preprint":false},{"pmid":"31876919","id":"PMC_31876919","title":"Acetate coordinates neutrophil and ILC3 responses against C. difficile through FFAR2.","date":"2020","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31876919","citation_count":183,"is_preprint":false},{"pmid":"26023106","id":"PMC_26023106","title":"GPR43 Potentiates β-Cell Function in Obesity.","date":"2015","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/26023106","citation_count":179,"is_preprint":false},{"pmid":"23489932","id":"PMC_23489932","title":"GPR43/FFA2: physiopathological relevance and therapeutic prospects.","date":"2013","source":"Trends in pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/23489932","citation_count":163,"is_preprint":false},{"pmid":"26075576","id":"PMC_26075576","title":"An Acetate-Specific GPCR, FFAR2, Regulates Insulin Secretion.","date":"2015","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/26075576","citation_count":152,"is_preprint":false},{"pmid":"36164984","id":"PMC_36164984","title":"Faecalibacterium prausnitzii Attenuates CKD via Butyrate-Renal GPR43 Axis.","date":"2022","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/36164984","citation_count":148,"is_preprint":false},{"pmid":"28075383","id":"PMC_28075383","title":"Soluble Fibre Meal Challenge Reduces Airway Inflammation and Expression of GPR43 and GPR41 in Asthma.","date":"2017","source":"Nutrients","url":"https://pubmed.ncbi.nlm.nih.gov/28075383","citation_count":145,"is_preprint":false},{"pmid":"30201970","id":"PMC_30201970","title":"Microbial metabolite sensor GPR43 controls severity of experimental GVHD.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/30201970","citation_count":126,"is_preprint":false},{"pmid":"17187590","id":"PMC_17187590","title":"The relationship between the effects of short-chain fatty acids on intestinal motility in vitro and GPR43 receptor activation.","date":"2007","source":"Neurogastroenterology and motility","url":"https://pubmed.ncbi.nlm.nih.gov/17187590","citation_count":126,"is_preprint":false},{"pmid":"33851870","id":"PMC_33851870","title":"Lung immune tone via gut-lung axis: gut-derived LPS and short-chain fatty acids' immunometabolic regulation of lung IL-1β, FFAR2, and FFAR3 expression.","date":"2021","source":"American journal of physiology. Lung cellular and molecular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/33851870","citation_count":124,"is_preprint":false},{"pmid":"31356781","id":"PMC_31356781","title":"Propionate suppresses hepatic gluconeogenesis via GPR43/AMPK signaling pathway.","date":"2019","source":"Archives of biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/31356781","citation_count":121,"is_preprint":false},{"pmid":"34530928","id":"PMC_34530928","title":"Commensal microbe-derived acetate suppresses NAFLD/NASH development via hepatic FFAR2 signalling in mice.","date":"2021","source":"Microbiome","url":"https://pubmed.ncbi.nlm.nih.gov/34530928","citation_count":120,"is_preprint":false},{"pmid":"17052194","id":"PMC_17052194","title":"The G-protein-coupled receptor 40 family (GPR40-GPR43) and its role in nutrient sensing.","date":"2006","source":"Biochemical Society transactions","url":"https://pubmed.ncbi.nlm.nih.gov/17052194","citation_count":111,"is_preprint":false},{"pmid":"27348268","id":"PMC_27348268","title":"An essential role of Ffar2 (Gpr43) in dietary fibre-mediated promotion of healthy composition of gut microbiota and suppression of intestinal carcinogenesis.","date":"2016","source":"Oncogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/27348268","citation_count":108,"is_preprint":false},{"pmid":"28692672","id":"PMC_28692672","title":"The short chain fatty acid receptor GPR43 regulates inflammatory signals in adipose tissue M2-type macrophages.","date":"2017","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/28692672","citation_count":108,"is_preprint":false},{"pmid":"31685604","id":"PMC_31685604","title":"Ketone body receptor GPR43 regulates lipid metabolism under ketogenic conditions.","date":"2019","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/31685604","citation_count":103,"is_preprint":false},{"pmid":"28727837","id":"PMC_28727837","title":"Differing roles for short chain fatty acids and GPR43 agonism in the regulation of intestinal barrier function and immune responses.","date":"2017","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/28727837","citation_count":103,"is_preprint":false},{"pmid":"26990063","id":"PMC_26990063","title":"Short-Chain Fatty Acid Acetate Stimulates Adipogenesis and Mitochondrial Biogenesis via GPR43 in Brown Adipocytes.","date":"2016","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/26990063","citation_count":101,"is_preprint":false},{"pmid":"16887331","id":"PMC_16887331","title":"Short-chain fatty acids induce acute phosphorylation of the p38 mitogen-activated protein kinase/heat shock protein 27 pathway via GPR43 in the MCF-7 human breast cancer cell line.","date":"2006","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/16887331","citation_count":95,"is_preprint":false},{"pmid":"29515566","id":"PMC_29515566","title":"The Metabolic Sensor GPR43 Receptor Plays a Role in the Control of Klebsiella pneumoniae Infection in the Lung.","date":"2018","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/29515566","citation_count":86,"is_preprint":false},{"pmid":"30448827","id":"PMC_30448827","title":"Butyrate Modulates Inflammation in Chondrocytes via GPR43 Receptor.","date":"2018","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/30448827","citation_count":85,"is_preprint":false},{"pmid":"28883043","id":"PMC_28883043","title":"FFAR2-FFAR3 receptor heteromerization modulates short-chain fatty acid sensing.","date":"2017","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/28883043","citation_count":83,"is_preprint":false},{"pmid":"27667443","id":"PMC_27667443","title":"Human and mouse monocytes display distinct signalling and cytokine profiles upon stimulation with FFAR2/FFAR3 short-chain fatty acid receptor agonists.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27667443","citation_count":81,"is_preprint":false},{"pmid":"32139755","id":"PMC_32139755","title":"Bifidobacterium animalis subsp. lactis GCL2505 modulates host energy metabolism via the short-chain fatty acid receptor GPR43.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/32139755","citation_count":80,"is_preprint":false},{"pmid":"34365090","id":"PMC_34365090","title":"Butyrate directly decreases human gut lamina propria CD4 T cell function through histone deacetylase (HDAC) inhibition and GPR43 signaling.","date":"2021","source":"Immunobiology","url":"https://pubmed.ncbi.nlm.nih.gov/34365090","citation_count":79,"is_preprint":false},{"pmid":"31694949","id":"PMC_31694949","title":"The G Protein-Coupled Receptor FFAR2 Promotes Internalization during Influenza A Virus Entry.","date":"2020","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/31694949","citation_count":75,"is_preprint":false},{"pmid":"33754024","id":"PMC_33754024","title":"GPR43 deficiency protects against podocyte insulin resistance in diabetic nephropathy through the restoration of AMPKα activity.","date":"2021","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/33754024","citation_count":74,"is_preprint":false},{"pmid":"29524208","id":"PMC_29524208","title":"Loss of FFAR2 promotes colon cancer by epigenetic dysregulation of inflammation suppressors.","date":"2018","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/29524208","citation_count":73,"is_preprint":false},{"pmid":"31100533","id":"PMC_31100533","title":"Short-chain fatty acids and FFAR2 as suppressors of bone resorption.","date":"2019","source":"Bone","url":"https://pubmed.ncbi.nlm.nih.gov/31100533","citation_count":72,"is_preprint":false},{"pmid":"38744220","id":"PMC_38744220","title":"GPR41 and GPR43: From development to metabolic regulation.","date":"2024","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/38744220","citation_count":69,"is_preprint":false},{"pmid":"22178946","id":"PMC_22178946","title":"Diet-induced obesity up-regulates the abundance of GPR43 and GPR120 in a tissue specific manner.","date":"2011","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/22178946","citation_count":69,"is_preprint":false},{"pmid":"34926327","id":"PMC_34926327","title":"Short-Chain Fatty Acid and FFAR2 Activation - A New Option for Treating Infections?","date":"2021","source":"Frontiers in cellular and infection microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/34926327","citation_count":67,"is_preprint":false},{"pmid":"35844801","id":"PMC_35844801","title":"Commensal microbe-derived SCFA alleviates atrial fibrillation via GPR43/NLRP3 signaling.","date":"2022","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35844801","citation_count":65,"is_preprint":false},{"pmid":"33597149","id":"PMC_33597149","title":"The Butyrate-Producing Bacterium Clostridium butyricum Suppresses Clostridioides difficile Infection via Neutrophil- and Antimicrobial Cytokine-Dependent but GPR43/109a-Independent Mechanisms.","date":"2021","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/33597149","citation_count":65,"is_preprint":false},{"pmid":"39833898","id":"PMC_39833898","title":"Akkermansia muciniphila and its metabolite propionic acid maintains neuronal mitochondrial division and autophagy homeostasis during Alzheimer's disease pathologic process via GPR41 and GPR43.","date":"2025","source":"Microbiome","url":"https://pubmed.ncbi.nlm.nih.gov/39833898","citation_count":60,"is_preprint":false},{"pmid":"37185889","id":"PMC_37185889","title":"Butyrate dictates ferroptosis sensitivity through FFAR2-mTOR signaling.","date":"2023","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/37185889","citation_count":59,"is_preprint":false},{"pmid":"36888629","id":"PMC_36888629","title":"Butyrate suppresses atherosclerotic inflammation by regulating macrophages and polarization via GPR43/HDAC-miRNAs axis in ApoE-/- mice.","date":"2023","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/36888629","citation_count":56,"is_preprint":false},{"pmid":"34801681","id":"PMC_34801681","title":"Lithium carbonate alleviates colon inflammation through modulating gut microbiota and Treg cells in a GPR43-dependent manner.","date":"2021","source":"Pharmacological research","url":"https://pubmed.ncbi.nlm.nih.gov/34801681","citation_count":54,"is_preprint":false},{"pmid":"33913592","id":"PMC_33913592","title":"Short chain fatty acids released by Fusobacterium nucleatum are neutrophil chemoattractants acting via free fatty acid receptor 2 (FFAR2).","date":"2021","source":"Cellular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/33913592","citation_count":51,"is_preprint":false},{"pmid":"31076530","id":"PMC_31076530","title":"Microbiota Metabolite Short-Chain Fatty Acids Facilitate Mucosal Adjuvant Activity of Cholera Toxin through GPR43.","date":"2019","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/31076530","citation_count":50,"is_preprint":false},{"pmid":"30209581","id":"PMC_30209581","title":"Decreased expression of G-protein-coupled receptors GPR43 and GPR109a in psoriatic skin can be restored by topical application of sodium butyrate.","date":"2018","source":"Archives of dermatological research","url":"https://pubmed.ncbi.nlm.nih.gov/30209581","citation_count":47,"is_preprint":false},{"pmid":"29689277","id":"PMC_29689277","title":"Butyrate ameliorated-NLRC3 protects the intestinal barrier in a GPR43-dependent manner.","date":"2018","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/29689277","citation_count":46,"is_preprint":false},{"pmid":"32997697","id":"PMC_32997697","title":"Acetic acid stimulates G-protein-coupled receptor GPR43 and induces intracellular calcium influx in L6 myotube cells.","date":"2020","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/32997697","citation_count":46,"is_preprint":false},{"pmid":"32404878","id":"PMC_32404878","title":"Leuconostoc mesenteroides fermentation produces butyric acid and mediates Ffar2 to regulate blood glucose and insulin in type 1 diabetic mice.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/32404878","citation_count":43,"is_preprint":false},{"pmid":"23327542","id":"PMC_23327542","title":"Evaluation of the relationship between GPR43 and adiposity in human.","date":"2013","source":"Nutrition & metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/23327542","citation_count":42,"is_preprint":false},{"pmid":"29477577","id":"PMC_29477577","title":"Similarities and differences between the responses induced in human phagocytes through activation of the medium chain fatty acid receptor GPR84 and the short chain fatty acid receptor FFA2R.","date":"2018","source":"Biochimica et biophysica acta. Molecular cell research","url":"https://pubmed.ncbi.nlm.nih.gov/29477577","citation_count":42,"is_preprint":false},{"pmid":"25633224","id":"PMC_25633224","title":"The short-chain fatty acid receptor GPR43 is transcriptionally regulated by XBP1 in human monocytes.","date":"2015","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/25633224","citation_count":41,"is_preprint":false},{"pmid":"26683635","id":"PMC_26683635","title":"Selective novel inverse agonists for human GPR43 augment GLP-1 secretion.","date":"2015","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/26683635","citation_count":41,"is_preprint":false},{"pmid":"34584017","id":"PMC_34584017","title":"GPR43 regulation of mitochondrial damage to alleviate inflammatory reaction in sepsis.","date":"2021","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/34584017","citation_count":38,"is_preprint":false},{"pmid":"27503855","id":"PMC_27503855","title":"The Neutrophil Response Induced by an Agonist for Free Fatty Acid Receptor 2 (GPR43) Is Primed by Tumor Necrosis Factor Alpha and by Receptor Uncoupling from the Cytoskeleton but Attenuated by Tissue Recruitment.","date":"2016","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/27503855","citation_count":36,"is_preprint":false},{"pmid":"36638713","id":"PMC_36638713","title":"Eucommia bark/leaf extract improves HFD-induced lipid metabolism disorders via targeting gut microbiota to activate the Fiaf-LPL gut-liver axis and SCFAs-GPR43 gut-fat axis.","date":"2023","source":"Phytomedicine : international journal of phytotherapy and phytopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/36638713","citation_count":35,"is_preprint":false},{"pmid":"32958255","id":"PMC_32958255","title":"Microbiota-derived short chain fatty acid promotion of Amphiregulin expression by dendritic cells is regulated by GPR43 and Blimp-1.","date":"2020","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/32958255","citation_count":34,"is_preprint":false},{"pmid":"34675921","id":"PMC_34675921","title":"Short Chain Fatty Acids Prevent Glyoxylate-Induced Calcium Oxalate Stones by GPR43-Dependent Immunomodulatory Mechanism.","date":"2021","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/34675921","citation_count":34,"is_preprint":false},{"pmid":"34975320","id":"PMC_34975320","title":"GPR43 activation-mediated lipotoxicity contributes to podocyte injury in diabetic nephropathy by modulating the ERK/EGR1 pathway.","date":"2022","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/34975320","citation_count":34,"is_preprint":false},{"pmid":"33356962","id":"PMC_33356962","title":"GPR43 regulates sodium butyrate-induced angiogenesis and matrix remodeling.","date":"2020","source":"American journal of physiology. Heart and circulatory physiology","url":"https://pubmed.ncbi.nlm.nih.gov/33356962","citation_count":33,"is_preprint":false},{"pmid":"38402237","id":"PMC_38402237","title":"FFAR2 expressing myeloid-derived suppressor cells drive cancer immunoevasion.","date":"2024","source":"Journal of hematology & oncology","url":"https://pubmed.ncbi.nlm.nih.gov/38402237","citation_count":31,"is_preprint":false},{"pmid":"35673595","id":"PMC_35673595","title":"The Bufei Jianpi Formula Improves Mucosal Immune Function by Remodeling Gut Microbiota Through the SCFAs/GPR43/NLRP3 Pathway in Chronic Obstructive Pulmonary Disease Rats.","date":"2022","source":"International journal of chronic obstructive pulmonary disease","url":"https://pubmed.ncbi.nlm.nih.gov/35673595","citation_count":31,"is_preprint":false},{"pmid":"28570808","id":"PMC_28570808","title":"Development and Characterization of a Fluorescent Tracer for the Free Fatty Acid Receptor 2 (FFA2/GPR43).","date":"2017","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28570808","citation_count":30,"is_preprint":false},{"pmid":"30134499","id":"PMC_30134499","title":"Neutrophil priming that turns natural FFA2R agonists into potent activators of the superoxide generating NADPH-oxidase.","date":"2018","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/30134499","citation_count":28,"is_preprint":false},{"pmid":"26412151","id":"PMC_26412151","title":"GPR43 - A Prototypic Metabolite Sensor Linking Metabolic and Inflammatory Diseases.","date":"2015","source":"Trends in endocrinology and metabolism: TEM","url":"https://pubmed.ncbi.nlm.nih.gov/26412151","citation_count":28,"is_preprint":false},{"pmid":"37864932","id":"PMC_37864932","title":"Sodium butyrate (SB) ameliorated inflammation of COPD induced by cigarette smoke through activating the GPR43 to inhibit NF-κB/MAPKs signaling pathways.","date":"2023","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/37864932","citation_count":28,"is_preprint":false},{"pmid":"36806339","id":"PMC_36806339","title":"Pulsatilla chinensis saponins improve SCFAs regulating GPR43-NLRP3 signaling pathway in the treatment of ulcerative colitis.","date":"2023","source":"Journal of ethnopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/36806339","citation_count":28,"is_preprint":false},{"pmid":"37287005","id":"PMC_37287005","title":"FFAR2 antagonizes TLR2- and TLR3-induced lung cancer progression via the inhibition of AMPK-TAK1 signaling axis for the activation of NF-κB.","date":"2023","source":"Cell & bioscience","url":"https://pubmed.ncbi.nlm.nih.gov/37287005","citation_count":27,"is_preprint":false},{"pmid":"25912043","id":"PMC_25912043","title":"Expanding Duplication of Free Fatty Acid Receptor-2 (GPR43) Genes in the Chicken Genome.","date":"2015","source":"Genome biology and evolution","url":"https://pubmed.ncbi.nlm.nih.gov/25912043","citation_count":27,"is_preprint":false},{"pmid":"34026223","id":"PMC_34026223","title":"Sodium butyrate protects against lipopolysaccharide-induced liver injury partially via the GPR43/ β-arrestin-2/NF-κB network.","date":"2020","source":"Gastroenterology report","url":"https://pubmed.ncbi.nlm.nih.gov/34026223","citation_count":27,"is_preprint":false},{"pmid":"25850624","id":"PMC_25850624","title":"Role of Free Fatty Acid Receptor 2 (FFAR2) in the Regulation of Metabolic Homeostasis.","date":"2015","source":"Current drug targets","url":"https://pubmed.ncbi.nlm.nih.gov/25850624","citation_count":26,"is_preprint":false},{"pmid":"32411444","id":"PMC_32411444","title":"Low Expression of FFAR2 in Peripheral White Blood Cells May Be a Genetic Marker for Early Diagnosis of Acute Myocardial Infarction.","date":"2020","source":"Cardiology research and practice","url":"https://pubmed.ncbi.nlm.nih.gov/32411444","citation_count":26,"is_preprint":false},{"pmid":"39116526","id":"PMC_39116526","title":"EGCG drives gut microbial remodeling-induced epithelial GPR43 activation to lessen Th1 polarization in colitis.","date":"2024","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/39116526","citation_count":24,"is_preprint":false},{"pmid":"27757758","id":"PMC_27757758","title":"Ligands at the Free Fatty Acid Receptors 2/3 (GPR43/GPR41).","date":"2017","source":"Handbook of experimental pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/27757758","citation_count":24,"is_preprint":false},{"pmid":"30867532","id":"PMC_30867532","title":"Alteration of GLP-1/GPR43 expression and gastrointestinal motility in dysbiotic mice treated with vancomycin.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/30867532","citation_count":23,"is_preprint":false},{"pmid":"33572500","id":"PMC_33572500","title":"Probiotic Activity of Staphylococcus epidermidis Induces Collagen Type I Production through FFaR2/p-ERK Signaling.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33572500","citation_count":23,"is_preprint":false},{"pmid":"38349207","id":"PMC_38349207","title":"Maternal Phlorizin Intake Protects Offspring from Maternal Obesity-Induced Metabolic Disorders in Mice via Targeting Gut Microbiota to Activate the SCFA-GPR43 Pathway.","date":"2024","source":"Journal of agricultural and food chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/38349207","citation_count":23,"is_preprint":false},{"pmid":"25089883","id":"PMC_25089883","title":"Effect of short chain fatty acids on the expression of free fatty acid receptor 2 (Ffar2), Ffar3 and early-stage adipogenesis.","date":"2014","source":"Nutrition & diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/25089883","citation_count":23,"is_preprint":false},{"pmid":"34168098","id":"PMC_34168098","title":"Novel GPR43 Agonists Exert an Anti-Inflammatory Effect in a Colitis Model.","date":"2022","source":"Biomolecules & therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/34168098","citation_count":22,"is_preprint":false},{"pmid":"37070532","id":"PMC_37070532","title":"Neuroprotective effect of short-chain fatty acids against oxidative stress-induced SH-SY5Y injury via GPR43-dependent pathway.","date":"2023","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/37070532","citation_count":21,"is_preprint":false},{"pmid":"38742466","id":"PMC_38742466","title":"Gut Microbiota-Derived 3-Hydroxybutyrate Blocks GPR43-Mediated IL6 Signaling to Ameliorate Radiation Proctopathy.","date":"2024","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/38742466","citation_count":20,"is_preprint":false},{"pmid":"34330996","id":"PMC_34330996","title":"Acetate sensing by GPR43 alarms neutrophils and protects from severe sepsis.","date":"2021","source":"Communications biology","url":"https://pubmed.ncbi.nlm.nih.gov/34330996","citation_count":20,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":51642,"output_tokens":9066,"usd":0.145458},"stage2":{"model":"claude-opus-4-6","input_tokens":13148,"output_tokens":4495,"usd":0.267172},"total_usd":0.41263,"stage1_batch_id":"msgbatch_0118RScg3WGaGkaZRtWZbtce","stage2_batch_id":"msgbatch_01Cpfzvtbj42aqp5oYZ5Te2s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2002,\n      \"finding\": \"GPR43 (FFAR2) was deorphanized as a G-protein-coupled receptor activated by short-chain fatty acids (SCFAs), with acetate as the primary agonist and propionate, butyrate, formate, and pentanoate also active; receptor activation was confirmed by Ca2+ mobilization, [35S]GTPγS binding assays, and GIRK channel coexpression in Xenopus oocytes; highest expression was found in immune cells.\",\n      \"method\": \"Ligand bank screening in yeast, transient transfection in mammalian cells (Ca2+ mobilization, [35S]GTPγS binding), Xenopus oocyte GIRK coexpression assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple orthogonal in vitro assays with reconstitution in heterologous systems, foundational deorphanization paper\",\n      \"pmids\": [\"12496283\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"FFAR2 (GPR43) was independently confirmed as a SCFA receptor expressed on peripheral blood leukocytes; acetate and propionate were the most potent agonists; receptor activation mobilized intracellular calcium in recombinant systems and in human granulocytes.\",\n      \"method\": \"Receptor cloning, calcium mobilization assay in recombinant cells and primary human granulocytes, RT-PCR expression analysis\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — functional assay in primary human cells, independent replication of deorphanization\",\n      \"pmids\": [\"12684041\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"SCFA-GPR43 signaling is necessary for normal resolution of inflammatory responses; GPR43-deficient mice showed exacerbated or unresolved inflammation in colitis, arthritis, and asthma models, with increased inflammatory mediator production by immune cells and increased immune cell recruitment; germ-free mice lacking SCFAs phenocopied GPR43 deficiency.\",\n      \"method\": \"GPR43 knockout mouse models (colitis, arthritis, asthma), cytokine measurement, immune cell recruitment assays, germ-free mouse experiments\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with multiple disease models and defined cellular phenotypes, highly cited foundational study\",\n      \"pmids\": [\"19865172\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"FFAR2 mediates SCFA-triggered GLP-1 secretion from intestinal L cells; SCFAs raised cytosolic Ca2+ in L cells consistent with Gq signaling; mice lacking ffar2 showed reduced SCFA-triggered GLP-1 secretion in vitro and in vivo and impaired glucose tolerance.\",\n      \"method\": \"Primary colonic culture GLP-1 secretion assay, Ca2+ imaging in primary L cells, Ffar2 knockout mice (in vitro and in vivo GLP-1 measurement, glucose tolerance test), quantitative PCR for receptor expression in FACS-sorted L cells\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — knockout mice with multiple orthogonal assays (secretion, Ca2+ signaling, glucose tolerance), replicated in vitro and in vivo\",\n      \"pmids\": [\"22190648\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"GPR43-mediated SCFA signaling in neutrophils drives chemotaxis; GPR43 acts as a bona fide chemotactic receptor through Gi proteins, activating PKB, p38, and ERK; PI3Kγ, Rac2, p38, and ERK (but not mTOR) are required for GPR43-dependent chemotaxis; chemotaxis was abolished in GPR43-knockout neutrophils.\",\n      \"method\": \"Bone marrow-derived neutrophil chemotaxis assays (polycarbonate filter, EZ-Taxiscan), GPR43 knockout mice, synthetic agonist phenylacetamide-1, pertussis toxin treatment, pharmacological and genetic inhibition of signaling intermediates, Rac1/2 activation assay\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO neutrophils with multiple pathway inhibitors and orthogonal chemotaxis methods; strong mechanistic dissection\",\n      \"pmids\": [\"21698257\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"GPR43 suppresses insulin signaling in adipocytes to inhibit fat accumulation; GPR43-deficient mice are obese on normal diet while adipose-specific GPR43 overexpression keeps mice lean even on high-fat diet; SCFAs activate GPR43 to promote metabolism of lipids and glucose in other tissues; effects were absent under germ-free conditions.\",\n      \"method\": \"GPR43 knockout mice, adipose-specific GPR43 transgenic mice, germ-free and antibiotic-treated mice, insulin signaling assays in adipocytes, body composition analysis, metabolic phenotyping\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — complementary gain- and loss-of-function mouse models with mechanistic insulin signaling readouts; germ-free controls\",\n      \"pmids\": [\"23652017\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"GPR43 on intestinal epithelial cells activates ERK1/2 and p38 MAPK signaling pathways in response to SCFAs, leading to production of chemokines and cytokines that recruit leukocytes and activate effector T cells; GPR43-deficient mice had reduced inflammatory responses and slower pathogen clearance.\",\n      \"method\": \"GPR43 knockout mice (ethanol, TNBS, C. rodentium models), primary colon epithelial cell isolation, immunohistochemistry, ELISA, flow cytometry, ERK/p38 signaling assays\",\n      \"journal\": \"Gastroenterology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO mice with multiple inflammation models, defined signaling pathway (ERK/p38 MAPK), multiple orthogonal readouts\",\n      \"pmids\": [\"23665276\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"SCFAs binding to GPR43 on colonic epithelial cells stimulates K+ efflux and membrane hyperpolarization, leading to NLRP3 inflammasome activation, which promotes gut epithelial integrity and protects against colitis.\",\n      \"method\": \"GPR43 knockout mice, dietary fiber/acetate intervention, electrophysiology (K+ efflux, hyperpolarization measurements), NLRP3 inflammasome activation assays, colitis models\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO mice plus electrophysiology and inflammasome pathway measurements; novel ionic mechanism identified\",\n      \"pmids\": [\"25828455\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"GPR43 in pancreatic β-cells potentiates glucose-stimulated insulin secretion (GSIS) via Gαq- and phospholipase C-dependent increases in IP3 and Ca2+; also promotes β-cell proliferation and differentiation gene expression; HFD-fed GPR43 KO mice develop glucose intolerance due to defective insulin secretion.\",\n      \"method\": \"GPR43 KO mice (HFD model), isolated murine and human islets ex vivo, Min6 cells, selective GPR43 agonist PA treatment, IP3 and Ca2+ measurements, β-cell mass quantification, gene expression analysis\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — mechanistic signaling (IP3/Ca2+/Gαq/PLC) confirmed in isolated islets and cell line with KO validation in vivo\",\n      \"pmids\": [\"26023106\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"FFAR2 signals through divergent G protein pathways: Gαq/11 pathway potentiates GSIS while Gαi/o pathway inhibits GSIS in mouse islets; acetate potentiates GSIS in an FFAR2-dependent manner; mouse and human FFAR2 display different signaling properties in response to selective agonists.\",\n      \"method\": \"Ffar2 knockout mice, isolated mouse and human islets ex vivo, FFAR2-specific agonists, hyperglycemic clamp studies, Gαq/11 and Gαi/o pathway pharmacology\",\n      \"journal\": \"Molecular endocrinology (Baltimore, Md.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — ex vivo islet assays with KO controls and selective pharmacological dissection of G protein pathways\",\n      \"pmids\": [\"26075576\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"GPR43 transcription in human monocytes is regulated by XBP1, which binds directly to the GPR43 promoter as a core cis element; TNFα induces GPR43 expression via XBP1 activation.\",\n      \"method\": \"5'-RACE mapping of TSS, luciferase reporter assays with stepwise deletions, site-directed mutagenesis, ChIP assay confirming XBP1 binding to endogenous GPR43 promoter, siRNA knockdown of XBP1, XBP1 overexpression\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — ChIP validation plus multiple mutagenesis/knockdown/overexpression approaches; strong mechanistic characterization of promoter\",\n      \"pmids\": [\"25633224\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"FFAR2 (Ffar2) promotes expansion of PYY-producing colonic enteroendocrine cells in response to fermentable carbohydrate (inulin), reducing food intake and preventing diet-induced obesity; this effect requires FFAR2 and involves increased PYY cell density and GLP-1 release.\",\n      \"method\": \"Ffar2 knockout mice, inulin-supplemented diet, enteroendocrine cell density measurements, intestinal organoids and colonic cultures, gut hormone measurements\",\n      \"journal\": \"Molecular metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO mouse model with cellular (enteroendocrine cell density) and hormonal readouts, supported by organoid experiments\",\n      \"pmids\": [\"28123937\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"GPR43 activation by SCFA acetate promotes intestinal IgA responses; mechanistically, acetate-GPR43 signaling induces dendritic cell expression of Aldh1a2, which converts Vitamin A to retinoic acid (RA), and RA then drives B-cell IgA class switching and IgA production.\",\n      \"method\": \"GPR43 knockout mice, B cell IgA class switching assays in vitro with WT vs GPR43-/- dendritic cells, Aldh1a2 expression analysis, RA signaling blockade experiments\",\n      \"journal\": \"Mucosal immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO mice plus defined in vitro mechanistic pathway (DC Aldh1a2 → RA → B cell IgA switching)\",\n      \"pmids\": [\"27966553\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"FFAR2 and FFAR3 interact to form a receptor heteromer in primary human monocytes and macrophages; the FFAR2-FFAR3 heteromer displays enhanced Ca2+ signaling (~1.5-fold vs homomeric FFAR2) and β-arrestin-2 recruitment (~30-fold vs homomeric FFAR3), lacks cAMP inhibition but gains p38 phosphorylation activity via Gαq and Gαi pathways.\",\n      \"method\": \"Proximity ligation assay in primary human monocytes/macrophages, bimolecular fluorescence complementation and FRET in HEK293 cells, Ca2+ signaling, β-arrestin-2 recruitment, cAMP, p38 phosphorylation assays, selective antagonists (CATPB, YM254890, pertussis toxin)\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods (PLA, BiFC, FRET) in primary and recombinant cells, pharmacological validation with selective inhibitors\",\n      \"pmids\": [\"28883043\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"GPR43 mediates SCFA-induced RegIIIγ and β-defensin expression in intestinal epithelial cells via activation of mTOR and STAT3 signaling pathways.\",\n      \"method\": \"GPR43 knockout mice, intestinal epithelial enteroids from WT and GPR43-/- mice, SCFA treatment, mTOR and STAT3 knockdown, AMP expression quantification\",\n      \"journal\": \"Mucosal immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO organoid model plus siRNA pathway validation; clean mechanistic dissection (SCFA→GPR43→mTOR/STAT3→AMP)\",\n      \"pmids\": [\"29411774\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"GPR43 activation results in induction of pro-inflammatory TNF-α in anti-inflammatory M2-type adipose tissue macrophages but not M1-type macrophages, suggesting distinct macrophage-type-dependent GPR43 functions in adipose tissue homeostasis.\",\n      \"method\": \"Gpr43-deficient mice, adipose-specific GPR43 transgenic mice, adipose tissue macrophage isolation, cytokine expression assays, M1/M2 macrophage differentiation\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO and transgenic mice with defined cellular readouts, but single lab study\",\n      \"pmids\": [\"28692672\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"GPR43-dependent ERK phosphorylation and NLRP3 inflammasome activation in non-hematopoietic host tissues mediates SCFA protection against GVHD; specifically propionate and butyrate signal through GPR43 for these protective effects.\",\n      \"method\": \"Multiple murine GVHD models, GPR43 knockout mice, co-housing/antibiotic treatment/exogenous SCFA administration, ERK phosphorylation assays, NLRP3 inflammasome assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple GVHD models with KO validation plus defined signaling (ERK/NLRP3); multiple mechanistic controls\",\n      \"pmids\": [\"30201970\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"FFAR2 promotes IAV internalization into host cells via a signaling cascade involving β-arrestin1 interaction with the β2-subunit of the AP-2 adaptor complex (AP2B1), facilitating clathrin-mediated endocytosis; FFAR2 also interacts with GRK2, GRK5, and GRK6 which are required for efficient IAV replication.\",\n      \"method\": \"siRNA knockdown of FFAR2 in A549 and RAW264.7 cells, co-immunoprecipitation (FFAR2–β-arrestin1, β-arrestin1–AP2B1), nuclear NP accumulation assay, virus internalization quantification, Barbadin inhibitor treatment, siRNA knockdown of AP2B1 and GRKs\",\n      \"journal\": \"Journal of virology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — Co-IP demonstrating protein interactions, KD phenotype with mechanistic pathway (FFAR2→β-arrestin1→AP2B1→clathrin endocytosis), multiple orthogonal controls\",\n      \"pmids\": [\"31694949\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Ffar2 on colonic ILC3s promotes their in situ proliferation and IL-22 production via AKT and STAT3 signaling; Ffar2 agonism differentially activates AKT or ERK; Ffar2 deficiency in ILC3s decreases IL-22+ CCR6+ ILC3s and impairs gut barrier function.\",\n      \"method\": \"ILC3-specific Ffar2 conditional analysis, Ffar2 agonism in colonic cultures, AKT/ERK/STAT3 pathway analysis, ILC3 proliferation measurement, IL-22 production assays, colonic injury and bacterial infection models\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — defined receptor-to-signaling pathway (Ffar2→AKT→STAT3→IL-22) with ILC3-specific functional readouts and infection phenotype\",\n      \"pmids\": [\"31628054\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Acetoacetate is identified as an endogenous agonist for GPR43 under ketogenic conditions; under fasting or ketogenic diet, plasma acetoacetate increases while SCFAs decrease; Gpr43-deficient mice show reduced weight loss and suppressed lipoprotein lipase activity during fasting.\",\n      \"method\": \"Ligand screening in heterologous expression system, Gpr43-deficient mice under fasting/ketogenic diet, plasma acetoacetate and SCFA measurement, lipoprotein lipase activity assay, gut microbiota composition analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — ligand identification in heterologous system plus KO mouse with defined metabolic phenotype under controlled nutritional conditions\",\n      \"pmids\": [\"31685604\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Propionate suppresses hepatic gluconeogenesis via GPR43 activation: GPR43 binding triggers intracellular Ca2+ increase → CaMKKβ activation → AMPK phosphorylation → downregulation of G6Pase and PEPCK; siRNA knockdown of GPR43 abolishes propionate-induced AMPK activation and anti-gluconeogenic effects.\",\n      \"method\": \"HepG2 hepatocytes, siRNA knockdown of GPR43, intracellular Ca2+ measurement, CaMKKβ inhibitor, AMPK phosphorylation assay, G6Pase/PEPCK expression analysis, glucose production assay\",\n      \"journal\": \"Archives of biochemistry and biophysics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro mechanistic dissection with siRNA KD, Ca2+ measurements, and kinase cascade delineation in human hepatocytes\",\n      \"pmids\": [\"31356781\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"GPR43 activation by acetate in pulmonary epithelial cells mediates antiviral interferon-β (IFN-β) response against RSV; IFNAR signaling is essential for acetate antiviral activity; effects were abolished in Gpr43-/- mice.\",\n      \"method\": \"Gpr43 knockout mice (RSV infection model), pulmonary epithelial cell lines with GPR43 activation/knockdown, IFN-β measurement, IFNAR blocking, viral load quantification, ISG expression analysis\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO mice plus cell line mechanistic studies linking GPR43 to IFN-β pathway, epistatic validation with IFNAR knockout\",\n      \"pmids\": [\"31332169\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Acetate-FFAR2 signaling coordinates neutrophil and ILC3 responses against C. difficile: in neutrophils, acetate-FFAR2 accelerates recruitment, facilitates inflammasome activation, and promotes IL-1β release; in ILC3s, acetate-FFAR2 augments IL-1R expression, boosting IL-22 secretion in response to IL-1β.\",\n      \"method\": \"FFAR2 knockout mice (acute CDI model), acetate administration, neutrophil recruitment/inflammasome/IL-1β assays, ILC3 IL-1R expression and IL-22 secretion measurement\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO mice with mechanistic dissection of two distinct cell type pathways (neutrophil inflammasome vs ILC3 IL-1R/IL-22)\",\n      \"pmids\": [\"31876919\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Acetic acid activates GPR43 in L6 skeletal muscle myotubes, inducing intracellular Ca2+ influx that activates calcineurin, leading to nuclear localization of MEF2A, PGC-1α, and NFATc1, thereby promoting slow-twitch fiber proliferation-related gene expression; GPR43 siRNA abolishes these effects.\",\n      \"method\": \"L6 myotube cells, GPR43 siRNA knockdown, Ca2+ imaging, calcineurin activity assay, nuclear localization assays for MEF2A/PGC-1α/NFATc1, RT-PCR\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — siRNA KD with Ca2+ and nuclear translocation measurements in cell line, but single lab study\",\n      \"pmids\": [\"32997697\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"GPR43 is expressed in enteroendocrine cells (PYY-positive, not 5-HT-positive) and mucosal mast cells in rat intestine, with protein localized to these specific cell types; no GPR43 was detected in smooth muscle or submucosa.\",\n      \"method\": \"RT-PCR, Western blotting, immunohistochemistry with antibody raised against rat GPR43 peptide fragment, co-localization with PYY and 5-HT markers\",\n      \"journal\": \"Cell and tissue research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct protein localization with specific antibody and co-localization markers, but no functional consequence directly tested\",\n      \"pmids\": [\"16453106\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"SCFAs activate GPR43 in MCF-7 breast cancer cells to selectively phosphorylate p38 MAPK and its downstream substrate HSP27 (at Ser-78 and Ser-82 but not Ser-15); propionate-induced Ca2+ elevation and p38 phosphorylation were inhibited by GPR43-specific siRNA.\",\n      \"method\": \"RT-PCR expression, intracellular Ca2+ measurement, cAMP assay, phospho-p38 and phospho-HSP27 Western blot, GPR43-specific siRNA knockdown\",\n      \"journal\": \"Cellular signalling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — siRNA KD with Ca2+ and kinase substrate measurements in cell line; moderate evidence from single lab\",\n      \"pmids\": [\"16887331\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"FFAR2 in adipocytes signals via the Gi/o–Gβγ–phospholipase C–PKC–MAPK kinase pathway to stimulate adipogenesis and mitochondrial biogenesis in brown adipocytes; acetate activates ERK and CREB via this pathway, with effects mimicked by a synthetic GPR43 agonist and impaired by GPR43 knockdown.\",\n      \"method\": \"Brown adipocyte cell culture, Gi/o inhibitor (PTX), Gβγ inhibitor, PLC inhibitor, MEK inhibitor, GPR43 knockdown, ERK/CREB phosphorylation assays, mitochondrial biogenesis markers, adipogenic gene expression\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological pathway dissection with KD validation in cell line, single lab\",\n      \"pmids\": [\"26990063\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Sodium butyrate protects against LPS-induced liver injury via a GPR43/β-arrestin-2/NF-κB pathway; butyrate treatment increases interaction between GPR43 and β-arrestin-2, and between β-arrestin-2 and IκBα, thereby suppressing NF-κB activation; protective effects were weakened in GPR43-KO mice and GPR43 siRNA-treated cells.\",\n      \"method\": \"GPR43 KO mice (LPS model), GPR43 siRNA in RAW264.7 cells, co-immunoprecipitation (GPR43–β-arrestin-2, β-arrestin-2–IκBα), NF-κB/TLR4 pathway Western blot, cytokine measurement\",\n      \"journal\": \"Gastroenterology report\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP demonstrating protein interactions with KO validation, but single lab study\",\n      \"pmids\": [\"34026223\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"FFAR2 signaling in MDSC suppresses T cell function through Gαq/calcium/PPAR-γ/Arg1 axis; FFAR2 deficiency in MDSCs reduces Arg1 expression, relieving L-Arginine consumption and restoring T cell activity in the tumor microenvironment; FFAR2 inhibition enhances response to immune checkpoint blockade.\",\n      \"method\": \"Whole/myeloid Ffar2 knockout mice (lung carcinogenesis models), flow cytometry, RNA sequencing, Western blotting, L-Arginine replenishment, PPAR-γ inhibition, Gαq/calcium pathway analysis\",\n      \"journal\": \"Journal of hematology & oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO models with defined signaling pathway and functional T cell readouts; single lab but multiple orthogonal approaches\",\n      \"pmids\": [\"38402237\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Butyrate promotes ferroptosis via FFAR2: FFAR2 activation by butyrate suppresses SLC7A11 via the FFAR2-AKT-NRF2 axis and suppresses GPX4 via the FFAR2-mTORC1 axis, both in a cAMP-PKA-dependent manner, leading to lipid ROS accumulation.\",\n      \"method\": \"Ferroptosis assays (RSL3/erastin), FFAR2 knockdown/overexpression, AKT/NRF2 pathway analysis, mTORC1 inhibition, SLC7A11 and GPX4 expression, cAMP-PKA pathway analysis, xenograft and colorectal carcinogenesis models\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic pathway dissection with KD and pharmacological tools in cell lines plus in vivo validation; single lab\",\n      \"pmids\": [\"37185889\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"GPR43 activation by SCFAs inhibits NLRP3 inflammasome-mediated atrial remodeling to protect against atrial fibrillation; GPR43 knockdown in HL-1 atrial cells abolished the protective effects of SCFAs on NLRP3 deactivation.\",\n      \"method\": \"Low/high fiber diet mouse model, burst pacing AF model, HL-1 cells with GPR43 knockdown, NLRP3 inflammasome activity assay, CaMKII phosphorylation and RyR2 phosphorylation measurement, collagen/fibrosis analysis\",\n      \"journal\": \"International journal of biological sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro KD mechanistic validation with in vivo diet model; single lab but defined signaling pathway\",\n      \"pmids\": [\"35844801\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"GPR43 activation by SCFA acetate in podocytes activates the ERK/EGR1 pathway, increasing LDLR expression and inhibiting cholesterol autophagy, leading to cholesterol accumulation and lipotoxic podocyte injury in diabetic nephropathy; GPR43 gene deletion or pharmacological inhibition prevents these effects.\",\n      \"method\": \"Diabetic GPR43-knockout mice, podocyte cell culture, BODIPY staining, cholesterol assays, ERK1/2 and EGR1 expression, LC3/p62/beclin1 autophagy markers, LDLR expression, GPR43 siRNA and pharmacological inhibition\",\n      \"journal\": \"International journal of biological sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO mice plus in vitro mechanistic pathway (GPR43→ERK→EGR1→LDLR/autophagy), single lab\",\n      \"pmids\": [\"34975320\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"FFAR2 mediates SCFA-induced SCFA-dependent innate defense against IAV through type 1 interferon (IFN-β) response in pulmonary epithelial cells; Gpr43-knockout mice lose the protective antiviral effects of dietary fiber/acetate.\",\n      \"method\": \"Gpr43 knockout mice (RSV model also covers IAV in context of antiviral signaling), pulmonary epithelial cell line FFAR2 activation, IFN-β measurement, IFNAR pathway analysis\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — already captured in RSV paper (PMID 31332169); same mechanistic pathway\",\n      \"pmids\": [\"31332169\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"GPR43 activation by acetate primes neutrophils for enhanced chemotaxis, oxidative burst, cytokine release, and upregulation of phagocytic receptors; acetate administration rescues wild-type but not GPR43-deficient mice from severe S. aureus sepsis.\",\n      \"method\": \"Human neutrophil priming assays, GPR43-deficient mice (S. aureus sepsis model), acetate administration, ROS/oxidative burst assay, cytokine measurement, phagocytic receptor expression, bacterial load quantification\",\n      \"journal\": \"Communications biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — human neutrophil functional assays plus KO mouse sepsis model; single lab\",\n      \"pmids\": [\"34330996\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Propionic acid activates GPR43 to enhance PINK1/PARKIN-mediated mitophagy in neuronal cells, while activating GPR41 to downregulate DRP1-mediated mitochondrial fission, thereby maintaining mitochondrial homeostasis in an Alzheimer's disease model.\",\n      \"method\": \"AD mouse model with oral propionate supplementation, cultured hippocampal neurons, GPR43 and GPR41 pathway analysis, DRP1/mitochondrial fission protein expression, PINK1/PARKIN mitophagy markers, cognitive behavioral tests\",\n      \"journal\": \"Microbiome\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo and in vitro with defined pathway (GPR43→PINK1/PARKIN mitophagy), but distinguishing GPR41 vs GPR43 roles requires care; single lab\",\n      \"pmids\": [\"39833898\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"FFAR2 (GPR43) is a seven-transmembrane G-protein-coupled receptor activated by short-chain fatty acids (primarily acetate, propionate, and butyrate) and ketone body acetoacetate, which couples to both Gαi/o (inhibiting cAMP, mediating chemotaxis) and Gαq/11 (mobilizing Ca2+, activating PLC/IP3, stimulating NLRP3 inflammasome and K+ efflux) pathways depending on cell type and ligand, and can also signal through β-arrestin-2 to suppress NF-κB; it drives diverse downstream effects including ERK/p38 MAPK activation, mTOR/STAT3 signaling, AMPK activation via CaMKKβ, and AKT/NRF2 modulation, with defined roles in neutrophil chemotaxis and priming, intestinal ILC3 proliferation and IL-22 production, GLP-1 and PYY secretion from enteroendocrine cells, insulin secretion potentiation in β-cells, suppression of adipocyte insulin signaling to regulate fat accumulation, antimicrobial peptide induction in intestinal epithelium, intestinal IgA responses via dendritic cell retinoic acid production, and antiviral IFN-β signaling in lung epithelial cells.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"FFAR2 (GPR43) is a G-protein-coupled receptor for short-chain fatty acids and the ketone body acetoacetate that transduces microbiota-derived metabolic signals into immune, metabolic, and epithelial barrier responses across diverse tissues [PMID:12496283, PMID:31685604]. It couples to Gαq/11 to mobilize intracellular Ca²⁺ and activate PLC/IP3, ERK/p38 MAPK, mTOR/STAT3, and NLRP3 inflammasome pathways, and to Gαi/o to inhibit cAMP and drive chemotaxis through PI3Kγ/Rac2, while also engaging β-arrestin-2 to suppress NF-κB signaling [PMID:26075576, PMID:21698257, PMID:25828455, PMID:34026223]. These divergent signaling cascades underpin FFAR2's roles in neutrophil chemotaxis and priming, ILC3 proliferation and IL-22 production, GLP-1 and PYY secretion from enteroendocrine cells, glucose-stimulated insulin secretion in β-cells, suppression of adipocyte insulin signaling, antimicrobial peptide induction via mTOR/STAT3, dendritic cell–driven IgA responses, and antiviral IFN-β production in pulmonary epithelium [PMID:31628054, PMID:22190648, PMID:26023106, PMID:23652017, PMID:29411774, PMID:27966553, PMID:31332169]. FFAR2 also forms functional heteromers with FFAR3 that alter signaling output in monocytes and macrophages [PMID:28883043].\",\n  \"teleology\": [\n    {\n      \"year\": 2002,\n      \"claim\": \"Resolving the orphan status of GPR43, SCFA ligand screening established that acetate, propionate, and butyrate activate this GPCR, with Ca²⁺ mobilization and GTPγS binding confirming functional coupling — founding the field of SCFA receptor biology.\",\n      \"evidence\": \"Ligand bank screening in yeast, Ca²⁺ mobilization and [³⁵S]GTPγS binding in mammalian cells, GIRK channel coexpression in Xenopus oocytes\",\n      \"pmids\": [\"12496283\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream G-protein identity not resolved\", \"No in vivo functional data\", \"Endogenous cellular context unknown\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Independent replication in primary human granulocytes confirmed FFAR2 as a functional SCFA receptor on immune cells, establishing that leukocytes are a primary site of FFAR2 action.\",\n      \"evidence\": \"Ca²⁺ mobilization in recombinant cells and primary human granulocytes, RT-PCR expression profiling\",\n      \"pmids\": [\"12684041\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific immune cell functions mediated by FFAR2 not yet defined\", \"G-protein coupling pathway not delineated\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Cellular localization studies placed FFAR2 protein in intestinal PYY-positive enteroendocrine cells and mucosal mast cells, while signaling studies in MCF-7 cells identified selective p38 MAPK and HSP27 phosphorylation downstream of FFAR2, beginning to define tissue-specific signaling.\",\n      \"evidence\": \"Immunohistochemistry with co-localization markers in rat intestine; siRNA knockdown with p38/HSP27 phosphorylation in MCF-7 cells\",\n      \"pmids\": [\"16453106\", \"16887331\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence of enteroendocrine localization not tested\", \"p38 pathway relevance in immune cells not established\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"The first loss-of-function in vivo study demonstrated that FFAR2 is required for resolution of inflammatory responses, as KO mice showed exacerbated colitis, arthritis, and asthma — establishing FFAR2 as a bona fide mediator of microbiota-immune communication.\",\n      \"evidence\": \"GPR43 knockout mice in colitis, arthritis, and asthma models; germ-free mice phenocopying KO\",\n      \"pmids\": [\"19865172\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cell-type-specific contributions not dissected\", \"Downstream signaling pathways in vivo not identified\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Mechanistic dissection resolved that FFAR2 functions as a Gi-coupled chemotactic receptor in neutrophils through PI3Kγ/Rac2/p38/ERK, while simultaneously showing that it drives GLP-1 secretion from L cells via Gq/Ca²⁺ — demonstrating cell-type-dependent G-protein coupling.\",\n      \"evidence\": \"KO neutrophil chemotaxis with pathway inhibitors; KO mouse GLP-1 secretion with Ca²⁺ imaging in primary L cells\",\n      \"pmids\": [\"21698257\", \"22190648\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How cell-type context determines Gi vs Gq preference unknown\", \"β-arrestin signaling arm not yet explored\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Complementary gain- and loss-of-function mouse models established that FFAR2 suppresses adipocyte insulin signaling to regulate fat accumulation and promotes intestinal epithelial ERK/p38 cytokine responses for pathogen clearance, extending FFAR2's role beyond immune cells to metabolic and barrier tissues.\",\n      \"evidence\": \"Adipose-specific transgenic and global KO mice with metabolic phenotyping; KO mice in colitis/infection models with ERK/p38 signaling assays\",\n      \"pmids\": [\"23652017\", \"23665276\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct adipocyte signaling intermediates downstream of insulin inhibition not fully mapped\", \"Whether epithelial and immune FFAR2 functions are synergistic or independent unclear\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Three studies resolved key signaling branches: FFAR2 activates NLRP3 inflammasome via K⁺ efflux in colonic epithelium for barrier protection, potentiates GSIS through Gαq/PLC/IP3/Ca²⁺ in β-cells, and displays species-specific divergent Gαq vs Gαi/o coupling — revealing that the same receptor can drive opposing metabolic outputs depending on G-protein engagement.\",\n      \"evidence\": \"KO mice with electrophysiology for K⁺ efflux/NLRP3; isolated islets with IP3/Ca²⁺ measurements and hyperglycemic clamps; selective agonist pharmacology on mouse vs human islets\",\n      \"pmids\": [\"25828455\", \"26023106\", \"26075576\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis for differential G-protein coupling not known\", \"Species differences between mouse and human FFAR2 complicate translation\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Identification of XBP1 as a transcriptional regulator binding the FFAR2 promoter in monocytes, induced by TNFα, established how FFAR2 expression is upregulated during inflammation.\",\n      \"evidence\": \"ChIP, luciferase reporters with mutagenesis, siRNA knockdown and overexpression of XBP1 in human monocytes\",\n      \"pmids\": [\"25633224\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Other transcription factors regulating FFAR2 not identified\", \"Whether XBP1 regulation applies in non-monocyte cell types unknown\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"FFAR2 was shown to promote enteroendocrine cell expansion for PYY production and to induce dendritic cell Aldh1a2 expression for retinoic acid–driven IgA class switching, revealing receptor functions in gut hormone homeostasis and adaptive mucosal immunity.\",\n      \"evidence\": \"KO mice with inulin diet and enteroendocrine cell quantification; KO mice with DC co-culture IgA switching assays and Aldh1a2 expression\",\n      \"pmids\": [\"28123937\", \"27966553\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signaling pathway linking FFAR2 to Aldh1a2 induction not defined\", \"Whether FFAR2 directly drives enteroendocrine progenitor differentiation or only proliferation unclear\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Discovery that FFAR2 and FFAR3 form functional heteromers with altered signaling properties (enhanced Ca²⁺, gain of β-arrestin-2 recruitment, loss of cAMP inhibition) introduced receptor heteromerization as a mechanism for SCFA signaling diversification in monocytes/macrophages; simultaneously, a β-arrestin-2–mediated anti-inflammatory pathway (suppressing NF-κB via IκBα stabilization) was delineated.\",\n      \"evidence\": \"PLA in primary monocytes, BiFC/FRET in HEK293, Ca²⁺/cAMP/p38 assays for heteromer; Co-IP of GPR43–β-arrestin-2 and β-arrestin-2–IκBα with KO validation for NF-κB suppression\",\n      \"pmids\": [\"28883043\", \"34026223\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological relevance of heteromer vs homomer ratio in vivo not determined\", \"β-arrestin-2/NF-κB finding from single lab awaits independent replication\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"FFAR2 was linked to antimicrobial peptide (RegIIIγ, β-defensin) induction in intestinal epithelium through mTOR/STAT3, and to GVHD protection through ERK/NLRP3 in non-hematopoietic tissues, broadening the receptor's epithelial defense repertoire.\",\n      \"evidence\": \"KO enteroids with mTOR/STAT3 knockdown for AMP expression; KO mice in multiple GVHD models with ERK/NLRP3 assays\",\n      \"pmids\": [\"29411774\", \"30201970\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How mTOR/STAT3 and NLRP3 pathways are differentially engaged in different epithelial contexts not resolved\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"A burst of discoveries expanded FFAR2 biology in four directions: identification of acetoacetate as an endogenous ketogenic agonist; definition of the Ca²⁺/CaMKKβ/AMPK pathway suppressing hepatic gluconeogenesis; demonstration that FFAR2 on ILC3s drives IL-22 via AKT/STAT3 for gut barrier defense; and the antiviral IFN-β response in lung epithelium against RSV.\",\n      \"evidence\": \"Heterologous ligand screening plus KO mice under ketogenic conditions; HepG2 siRNA with Ca²⁺/AMPK cascade; ILC3 conditional analysis with AKT/STAT3/IL-22; KO mice in RSV model with IFN-β measurement\",\n      \"pmids\": [\"31685604\", \"31356781\", \"31628054\", \"31332169\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of acetoacetate vs SCFAs under mixed metabolic states unknown\", \"Whether ILC3 and neutrophil FFAR2 pathways are coordinated in vivo not fully resolved\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"FFAR2 was found to facilitate influenza virus internalization via β-arrestin-1/AP2B1/clathrin-mediated endocytosis, with GRK2/5/6 involvement — an unexpected pro-viral function distinct from its antiviral IFN-β activity in epithelial cells.\",\n      \"evidence\": \"siRNA knockdown of FFAR2 in A549/RAW264.7 cells, Co-IP of FFAR2–β-arrestin-1 and β-arrestin-1–AP2B1, virus internalization quantification\",\n      \"pmids\": [\"31694949\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How pro-viral endocytosis and antiviral IFN-β functions coexist in the same cell type not reconciled\", \"In vivo relevance of FFAR2 in IAV pathogenesis not tested with KO mice\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"FFAR2 was shown to coordinate innate immunity against C. difficile by accelerating neutrophil inflammasome/IL-1β release and upregulating ILC3 IL-1R/IL-22 — establishing a two-cell-type cooperative circuit mediated by a single receptor.\",\n      \"evidence\": \"FFAR2 KO mice in acute CDI model with neutrophil and ILC3 functional assays\",\n      \"pmids\": [\"31876919\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether this cooperative circuit operates in other enteric infections not tested\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"FFAR2 on MDSCs was shown to suppress anti-tumor T cell responses through Gαq/Ca²⁺/PPARγ/Arg1 axis, and FFAR2 inhibition enhanced checkpoint blockade — defining a tumor-promoting immunosuppressive function of FFAR2 distinct from its anti-inflammatory roles.\",\n      \"evidence\": \"Myeloid-specific Ffar2 KO mice in lung carcinogenesis, RNA-seq, L-Arg replenishment, PPARγ inhibition\",\n      \"pmids\": [\"38402237\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Generalizability across tumor types not established\", \"Whether FFAR2 MDSC function is ligand-specific not resolved\", \"Single lab study\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"FFAR2 was linked to ferroptosis induction via dual suppression of SLC7A11 (through AKT/NRF2) and GPX4 (through mTORC1) in a cAMP-PKA-dependent manner, expanding the receptor's role to regulated cell death.\",\n      \"evidence\": \"FFAR2 knockdown/overexpression with ferroptosis assays, AKT/NRF2 and mTORC1 pathway analysis, xenograft models\",\n      \"pmids\": [\"37185889\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological relevance of FFAR2-driven ferroptosis in normal tissue not established\", \"cAMP-PKA dependence seems at odds with Gi-mediated cAMP inhibition — reconciliation needed\", \"Single lab study\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Major unresolved questions include the structural basis for FFAR2's differential G-protein coupling across cell types, the physiological balance between pro-viral and antiviral FFAR2 functions, the in vivo stoichiometry and significance of FFAR2-FFAR3 heteromers, and whether FFAR2's tumor-promoting immunosuppressive activity can be therapeutically targeted without compromising its protective immune and metabolic roles.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No cryo-EM or crystal structure of FFAR2 in active state with different G proteins\", \"Lack of conditional tissue-specific KO studies distinguishing cell-autonomous vs non-cell-autonomous effects in most contexts\", \"Species differences between mouse and human FFAR2 pharmacology limit translational confidence\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [0, 1, 19]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [5, 8, 28]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 1, 13, 24]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [17]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 1, 4, 8, 9, 13, 25, 26]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [2, 4, 12, 18, 22, 33]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [5, 19, 20]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [29]}\n    ],\n    \"complexes\": [\n      \"FFAR2-FFAR3 heteromer\"\n    ],\n    \"partners\": [\n      \"FFAR3\",\n      \"ARRB2\",\n      \"ARRB1\",\n      \"AP2B1\",\n      \"GRK2\",\n      \"XBP1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}